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Immunoassay is a bioanalytical test, which utilizes the specific binding capability the antibody 
and the target analyte have towards each other, in order to detect different analytes from the 
samples. The miniaturized, polymeric microfluidic immunoassays, called as immunochips 
combine the cheap material costs, disposability and fast analysis. They enable large amounts of 
samples to be screened fast, which assists prognostication of many hazardous diseases. 
However, the development is not a straightforward process as the antibodies are delicate 
molecules and easily denatured when coupled to polymers. The functional application 
demands both careful planning regarding the surface modification of the substrate and the 
choice of the antibody immobilization method as they both have a major impact on the 
functioning of the application.   
In this thesis, the preliminary results of α-MPA Fab F5 immobilization onto SU-8 surface via 
residual epoxy groups are shown. Two different approaches are presented: random covalent 
and IDA-Co chelation, oriented immobilization. Both methods were studied in terms of 
different immobilization parameters (antibody incubation time, antigen amount, incubation 
buffer, SU-8 surface modification and both, SU-8 and antibody stability) and compared to each 
other. In addition, the possibility to use bare SU-8 as a MALDI base was studied and 
construction of a SU-8 immunoassay chip, where an innovative immobilization method based 
on position-selectivity and capillary action as the power source were used, was presented.  
This thesis serves as a comprehensive guideline for the follow-up studies of the antibody 
immobilization onto SU-8 surface. These preliminary results indicate that the antibody 
immobilization onto SU-8 with both of the presented immobilization methods is feasible. The 
comparison studies showed that the random immobilization was better in over 80 % of the 
studied cases. Despite the higher antibody efficiency responses the random immobilization 
offered, the better repeatability obtained in the oriented immobilization would favor it at least 
while thinking the functional applications. In MALDI studies, the sensitivity was still 
inadequate. In the immunochip studies, a correct contact angle (42º) and the layer parameters 
(thickness: 14.8 µm, consecutive row distance: 23 µm), which yielded the correct functioning 
of the presented application, were determined.   
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iii 
 
AALTO-YLIOPISTO    DIPLOMITYÖN 
SÄHKÖTEKNIIKAN KORKEAKOULU   TIIVISTELMÄ 
Tekijä: Marianne Leinikka 
Työn nimi: Rekombinanttivasta-aineilla pinnoitetut, mikrofluidistiset SU-8 sovellukset 
Päivämäärä: 26.5.2014                     Kieli: Englanti                        Sivumäärä:  97 +15 
Koulutusohjelma: Bioinformaatioteknologia 
Valvoja: Prof. Sami Franssila 
Ohjaajat: FT Tarja Nevanen, FT Ville Jokinen 
Vasta-ainemääritys perustuu vasta-aineen ja antigeenin väliseen spesifiseen sitoutumiseen, 
jonka avulla voidaan määrittää erilaisia aineita näytteistä. Mikrofluidistiset, polymeeriset 
vasta-ainesirut, jotka ovat perinteisen määrityksen miniaturisointeja, mahdollistavat halvat 
materiaalikustannukset, kertakäyttöisyyden ja nopean analysoinnin. Niiden avulla pystytään 
seulomaan nopeasti suuriakin näytemääriä, mikä edesauttaa mm. useiden tautien diagnosointia. 
Tällaisten sirujen valmistus ei kuitenkaan ole yksinkertaista, koska vasta-aineet herkkinä 
molekyyleinä denaturoituvat helposti kiinnityksen yhteydessä. Toimiva vasta-ainesiru vaatii 
sekä tarkkaa suunnittelua alustan että kiinnitysmenetelmän valinnan suhteen.  
Tässä diplomityössä esitetään ensimmäiset tulokset α-MPA Fab F5 rekombinanttivasta-aineen 
kiinnittämisestä SU-8:n pintaan valottumisessa vapaaksi jäävien epoksiryhmien avulla. Työssä 
käsitellään kahden eri kiinnitysmenetelmän, suoran (satunnainen, kovalenttinen) ja suunnatun 
(IDA-Co), optimointia vasta-aineen inkubaatioajan, antigeenin määrän, inkubaatioliuoksen, 
pinnan käsittelyn sekä pinnan että vasta-aineen stabiilisuuden suhteen. Menetelmiä myös 
verrattiin toisiinsa. Työssä tutkittiin SU-8:n soveltuvuutta MALDI-mittausalustaksi. Lisäksi 
työssä toteutettiin täysin SU-8:sta valmistettu siru, jonka toiminta perustuu kapillaari-ilmiöön 
ja kanavien rakenteeseen koodattuun ja täysin uudenlaiseen, paikka-selektiiviseen 
kiinnitykseen.  
Diplomityö toimii kattavana ohjeena jatkotutkimuksille vasta-aineiden kiinnittämisestä SU-8 
pintaan. Työssä saadut tulokset osoittavat, että vasta-aineen kiinnitys SU-8 pintaan on 
mahdollista molemmilla menetelmillä. Suora kiinnitysmenetelmä osoittautui yli 80 % kokeista 
orientoitua menetelmää paremmaksi. Lopputuotetta ajatellen, orientoidun kiinnityksen tulosten 
parempi toistettavuus on kuitenkin toivottavampaa. MALDIn sensitiivisyys ei vielä ollut 
riittävä SU-8 käyttöön mittausalustana. Vasta-ainesirututkimuksissa sen sijaan pystyttiin 
osoittamaan oikea kontaktikulma (42º) ja SU-8 kanavarakenteiden oikeat parametrit (paksuus: 
14.8 µm ja kuvioriviväli: 23 µm), joiden avulla siru toimi halutunlaisesti.  
Avainsanat: SU-8, Fab, rekombinanttivasta-aine, mikrofluidistiikka, polymeeri, vasta-aineen 
kiinnitys 
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1 Introduction 
1.1 Microfluidics and immunoassays 
Immunoassay is a bioanalytical test to detect the concentrations of analytes from the samples by 
utilizing the specific binding capability the antibody and the target analyte have towards each 
other. By combining microfluidics, the art of handling small amounts of liquids in micro scale, 
to immunoassays a new diagnostic platform is created. Even though the history of this platform 
is still rather short, both immunoassay types, homogenous (immunoreaction happens in soluble 
phase) and heterogenous (one of the immunoreagents requires to be immobilized) have already 
been successfully implemented to the microfluidics [1]. Immunoassay markets are attractive as 
assays are performed in high quantities by centralized laboratories and there is a wide range of 
potential users both in developed and developing countries (e.g. point-of-care (POC) and home 
diagnostics applications for the former and simple diagnostic devices for the latter [2]).  
 
The reason why these miniaturized immunoassay chips has gained attention from the 
conventional immunoassays is the improvements they offer: lower consumption of reagents 
(from 100 µl to 1 µl), decreased analysis time, disposability and increased sensitivity to mention 
a few [3-4]. In addition, these devices can be controlled passively by means of diffusion and / or 
capillary action [3] or by utilizing interesting innovations (e.g. liquid control by air evacuation 
[4]). The lack of need of external energy source makes possible to fabricate simple and easy-to-
use, portable devices with impressively low detection limit in the attomolar (aM) range [5-6]. In 
addition to more technical reasons, one motivation fact is the urging need to be able to screen 
fast different clinically important antigens, like C-reactive protein (CRP). CRP is a major acute-
phase reactant protein (117.5 kDa), which is often used as a biomarker for the prognostication 
of cardiovascular events [7]. The clinically relevant detection limit of CRP is 3 mg/l [8].  
 
The idea to implement antibodies to the microfluidic platform originates from the successful 
implementation of the deoxyribonucleic acid (DNA) to the chip structure. One example of a 
functional DNA chip is the polymerase chain reaction (PCR) chip, which multiplies the DNA 
sequence thousands of times [9]. But the construction of a functional immunoassay chip similar 
to DNA chip is not that simple. There are several reasons to support the argument: antibodies 
(and proteins in general) are chemically and structurally much more complex and heterogenous 
compared to DNA, their concentration varies a lot in a single biological sample, they have a 
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poor resistance towards heat and they are also amphiphilic molecules with pronounced surface 
activity (DNA constitutes of equally negatively charged nuclei acids). Antibodies may denature 
when immobilized to foreign surfaces like polymers, which makes the coupling of them to 
microfluidic devices challenging [5].   
Microfluidic immunoassays are fabricated in silicon, glass, polymer or their combinations [1, 
3,5]. Silicon, which is a traditional semiconductor industry material, and glass have several 
limitations set by their material properties and fabrication processes, which have directed the 
material choice to polymers [1,3,5]. Silicon, for instance, is not optically transparent within the 
ultraviolet (UV) / visible area and the microfabricated glass channels have often a curved 
bottom, which complicates the detection. Instead, polymers are a wide group with highly 
diverse physical and chemical properties. They have reduced material costs, which allow the 
fabrication of disposable devices (elimination of cross-contamination). Besides polymers are 
available in multiple different formats from foams to films, wafers to powders and have high 
gas permeability (depending on the application, this may be advantage or disadvantage). Many 
polymers are also transparent allowing the use of different optical detection methods suitable for 
diagnostics (e.g. fluorescence) and are often naturally biocompatible. The copolymerization of 
two or more polymers enables further increase in material properties. [10-11] 
Nevertheless, the most dominant feature to support the use of polymers is the diversity they 
offer with fabrication methods [11]. Polymers can be fabricated with wide range of methods, 
which are also compatible with the conventional microfabrication techniques. Harmful particles 
or residues, which are often generated during the processing of the traditional materials (e.g. due 
to usage of harsh chemicals), can be prevented by the choice of less contaminating processes.  
Roughly, the polymer fabrication techniques can be divided into two: direct and replication 
techniques. The difference between these groups is the principle of how the modification is 
applied. Direct techniques aim to transfer the designed pattern to polymer by irradiating the 
polymer with energy source either through mask or by beam scanning without the mask. The 
energy source can be UV-light, laser, X-ray or a charged particle beam. Direct techniques are 
highly developed and mainly used in the academic world, because they are well suited for 
prototype fabrication.  
In replication techniques, the inverse structure of the master (also called as mould) is transferred 
to the polymer either by casting, moulding or embossing. The master is either hard (e.g. silicon 
[12]) or soft (e.g. polymer [13]). The fabrication of master is the most time-consuming and 
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expensive step within the replication techniques. But because the single master can produce 
even hundreds of thousands of replicas, different replication methods possess great industrial 
and economical potential. [10] In casting (e.g. replica moulding) and moulding (e.g. injection 
moulding) processes polymer in its liquid form is either poured or injected to the master, 
respectively. Embossing shapes the softened but still solid polymer by pressing the master 
against the surface of the polymer. Pressure, light, heat or their combination is often applied to 
enhance the embossing process (e.g. pressure in nanoimprint lithography (NIL), light in UV-
NIL and heat in hot-embossing).  
Currently, the most dominant material for microfluidic immunoassays is polydimethylsiloxane 
(PDMS) [1,3,5]. There are several studies showing PDMS is a suitable material for antibodies 
[4, 6, 14-17]. The immunoassays are made either entirely on PDMS [15] or by combining 
several materials [14]. The advantages of PDMS are the well-known material properties, a high 
degree of biocompatibility and fast and cheap fabrication method, which does not involve the 
cleanroom environment [3]. The PDMS based applications are usually fabricated via casting 
(replication technique, figure 1). Li et al. [7], for instance, fabricated a PDMS microfluidic 
immunoassay based on heterogenous sandwich assay to detect CRP by fluorescence (figure 1). 
The chip (length: 28 mm, width: 28 mm, thickness: 3 mm) was constructed of two separate 
PDMS layers bonded to each other by oxidation treatment in a plasma system. Both layers were 
obtained using previously mentioned casting: the base (flat slab) without and the layer with five 
microfluidic channels (length: 17 mm, width: 150 µm width, thickness: 35 µm) with silicon 
master. The fluids were delivered to the chip by pressure-driven flow utilizing syringe pumps. 
They reached detection limit of 0.54 µg/ml. Other implemented polymers in microfluidic 
immunoassays include polystyrene (PS) [18], cycloolefic copolymers (COC) [19], polymethyl 
methacrylate (PMMA) [12, 20] and polycarbonate (PC) [1, 5].  
 
Figure 1. Microfluidic PDMS immunoassay chip for CRP detection (on left). The chip was 
fabricated by PDMS casting (on right). From ref. [7, 10 (adapted)].  
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1.2 Surface modification and antibody coupling 
The most crucial step in construction of a heterogenous immunoassay chip is the coupling of the 
antibody as it defines the achievable detection limit for the assay [4]. The large surface-to-
volume ratio, which on the other hand enables short diffusion distances and therefore fast 
reactions, allows a large surface for immunoagents to interact with. Antibodies (and proteins in 
general) are highly prone to nonspecific adsorption by e.g. hydrophobic interactions [1]. This 
tendency is enhanced by the hydrophobic nature the polymers (e.g. PDMS and PMMA), which 
are often used in microfabrication, have [5]. As the nonspecific adsorption results in high degree 
of background signal, the assay performance is degraded both in sensitivity and selectivity [1,4]. 
Therefore different surface modification methods are applied to improve the surface control 
during antibody coupling to the microfluidic surface.   
 
Potential surface modifications are either physical or chemical [5]. One example of a familiar 
physical surface modification is the Reactive Ion Etching (RIE), which is an oxygen plasma 
treatment, which both activates hydroxyl groups and increases surface roughness [21]. There are 
many studies indicating the RIE-treated surface both alleviates the nonspecific adsorption and 
increases surface roughness thereby improving the assay sensitivity [1, 21-22]. For example, in 
the study of Yuan et al. [22], root mean square (RMS) roughness value for PMMA increased 
from 0.232 to 2.608 with plasma oxidation treatment. Examples of chemical surface treatments 
are polymer grafting (e.g. UV-grafting of polyacrylic acid (PAA) on PMMA [20]), addition of 
self-assembled monolayers (SAMs) (e.g. 16-mercapto-hexadeconic acid (16-MHA) on gold 
coated PS substrate [18]) or amphiphilic polymers (e.g. second generation amphiphilic polymers 
poly(DMA-r-mPEGMA-r-NAS) and poly(BMA-r-mPEGMA-r-NAS on COC [19]) and sol-gel 
technology (e.g. Al2O3 sol-gel in (BMA)x-(MAOPTMS)y modified microchannels) [12]).  
 
Another advantage often associated to surface modification is the yielding of higher surface 
loadings compared to the nontreated surfaces [1, 20, 22]. This is important especially with 
microfluidic immunoassays as the total surface area is very small compared to the conventional 
immunoassay surfaces and therefore it is important to have all the antibodies fully functional. 
Wen et al. [20], for example, were able to improve the detection limit manyfold. They treated 
PMMA surface with oxygen plasma (20 sccm, 300W, 30s) and then UV-grafted PAA to formed 
hydroxyl groups prior attaching the antibody through linker molecule. Assay sensitivity can also 
be improved by simple means of microstructuring. The structuring of a simple channel design 
by PDMS microposts of 30 µm in height increased the total surface area 1.75-fold compared to 
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the flat area [23]. The fluorescence signal amplification in the performed sandwich assay 
showed linear dependence of the relative surface area of the post structures.  
 
The actual coupling of antibodies to polymer is done either via physical adsorption, covalent 
coupling or bio-specific immobilization [24]. The chosen method is decided case-specific, but 
with microfluidic applications, the covalent coupling has been the mainstream method [5]. The 
main target in immobilization is to maintain the conformation and functionality of the antibody 
by positioning the antigen-binding site towards solution phase in a correct incubation conditions 
(figure 2). Even though the high surface coverage is desired, the orientation of the antibodies 
should be loose enough to avoid steric obstruction [24]. The latter two immobilization methods, 
covalent coupling and bio-specific immobilization, are often associated to optimal orientation 
due to more controlled and specific reactions between the surface and the antibody molecule 
and therefore higher antibody activity compared to physical adsorption [25]. Physical 
adsorption is based on the weak interactions and antibodies can land in any possible orientation 
on the surface (figure 2).  
 
 
Figure 2. In optimized orientation of antibody, antigen-binding site is towards the solution phase 
which yields high surface coverage and maintained antibody activity. Adapted from ref. [24].  
 
 
The immobilized antibody is often a natural antibody, like immunoglobulin G (IgG) with 
mammalian origins [12, 18-19]. However, the detection sensitivity would be enhanced by the 
usage of genetically engineered, recombinant antibody fragments, like antigen-binding fragment 
(Fab). Their small size enables more fragments to be immobilized in the same area compared to 
the intact antibodies. Recombinant Fabs are truncated antibodies, which lack the Fc part of the 
IgG. One way to develop recombinant antibodies is the phage display technique [26], which 
links the phenotype to the genotype (antigen-binding behaviour to coding genes). Antibodies 
binding to desired targets can be selected from the phage display antibody libraries. 
Furthermore, it is possible to tailor the properties of the antibody fragment e.g. by adding 
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affinity tags to the C-terminus of the heavy chain. An example of a tag is a histide (His) -tag 
[27]. The tag is especially advantageous in the antibody coupling as it enables the 
immobilization of the fragment in an oriented manner [24]. Moreover, fast and efficient 
production, small size and high surface loadings are numbered among the advantages of the 
antibody fragment [27]. In the study of Brockmann et al. [27], Fabs offered 3-folds higher 
binding capacity, faster kinetics and better detection limit of thyroid-stimulating hormone 
(TSH) compared to the whole monoclonal antibodies (0.09 mIU/L TSH and 0.26 mIU/L TSH, 
respectively). Despite the advantages the recombinant fragments offer, their utilization is not 
widespread within the conventional immunoassays [27]. Therefore, the studies based on 
microfluidic supports are also scarce or lacking completely.  
1.3 Scope of the thesis 
In this thesis we study the recombinant Fab fragment immobilization onto SU-8, an epoxy-
based photoresist. SU-8 is widely used in microfluidics, because of mechanical reliability, 
chemical resistance to solvents, acids and bases as well as easy fabrication by photolithography 
[27]. Even though SU-8 has adequate biocompatibility [29] and reactive epoxy groups capable 
of biomolecule coupling after fabrication [28, 30-32], comparatively few studies exist on 
antibody immobilization. In most of the previous studies, antibodies have been immobilized via 
covalent attachment onto SU-8 surface [28, 31-33].  
We demonstrate the feasibility of His6-tagged Fab (mycophenolic acid (MPA) Fab) 
immobilization onto SU-8 surface and the construction of an immunoassay chip, which is made 
entirely of SU-8. Two different immobilization methods, random covalent and iminodiacetic 
acid (IDA) - cobalt (Co) chelation immobilizations [34] were optimized. Also, the comparison 
between these in terms of antibody incubation time, antigen concentration, biofouling 
resistance, wet and dry storing, pH of the immobilization buffer and the effect of surface 
patterning is presented. At least to our knowledge, studies on immobilization of recombinant 
Fab fragments with His-tags have not been presented before for SU-8 surface. In addition, the 
few intact antibody immobilization studies found utilized planar SU-8 excluding one study 
where antigens were immobilized instead of antibodies on nanopatterned SU-8 [35]. 
At the moment, the detection methods in microfluidic immunoassays are mainly comprised by 
fluorescence, surface plasmon resonance (SPR) and electrochemical detection [5]. The previous 
studies with SU-8 have always been based on fluorescence detection. Therefore, the potential to 
use SU-8, either as planar or nanopatterned surface, in detection of the interaction between 
7 
 
antibody and antigen with matrix assisted laser desorption / ionization (MALDI) mass 
spectrometry (MS) is incorporated to this thesis. Previous study of Hua et al. [36] demonstrated 
the usage of SU-8 as a MALDI base, but with a bulk modified version. They coupled the typical 
MALDI matrix material α-cyano-4-hydroxycinnamic acid (HCCA) covalently into SU-8 via 
cationic photopolymerization reaction.  
In addition to recombinant antibody immobilization the novelty presented in this thesis lies in 
the directed capillary flow by which the recombinant antibody solution is selectively positioned 
only to a certain compartment of the chip structure.  The technique is based on our own findings 
[37]. Position-selective immobilization enables the simultaneous analysis of different antigens 
in a single microfluidic device [5]. It is not a new technique within the microfluidic 
immunoassays as Bernard et al. [15] and Hashimoto et al. [23] have shown. However, in their 
studies the position-selectivity was incorporated into the fabrication process. In our application 
the position-selectivity is encoded in the design of the microfluidic structure.  
In order to assess the aims, three main questions were identified:  
1. Which of the two developed immobilization concepts, random or oriented 
immobilization offer higher antibody fragment activity after immobilization process? 
2. Is bare SU-8 surface suitable for MALDI detection? 
3. Is it possible to create a functional immunoassay prototype made entirely of SU-8? 
1.4 Structure of the thesis 
The literature part of this thesis is divided into five chapters. Chapter two explains the basic 
principles of passive microfluidics – how spontaneous flow of liquids is possible in micro scale 
channels and what unique properties micro world brings not seen in the macro world. Chapter 
three concentrates on the base material of all the tests: negative photoresist SU-8. This chapter 
explains widely the properties and fabrication and modification of SU-8. The antibody structure, 
the concept of immunoassay and the recombinant Fab fabrication are explained in chapter four. 
Chapter five describes the existing antibody immobilization methods on substrate surface and 
explains which part of the antibody molecule enables the immobilization. The differences 
between the intact antibody and fragment immobilizations are reviewed. This chapter also 
reviews the current state of antibody immobilization onto SU-8 substrate. The main points in the 
literature part of this thesis are the base material SU-8 and its properties as well as antibody 
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immobilization on polymer support. Therefore homogenous immunoassays and other supports 
than polymers and SU-8 are excluded.  
The experimental part consists of three parts: preliminary planning, system-setup and proof-of-
concept (figure 3). Preliminary planning has been done prior this thesis. System-setup step 
involves the development of two different immobilization concepts, which were both developed 
to be suitable for SU-8 immobilization. The last part, the proof-of-concept presents the drafting 
and preliminary testing of the easy-to-use heterogenic assay based on the capillary flow, which 
demands only minimal activity of the end user and is made entirely of SU-8.  
 
Figure 3. A three-step process flow diagram of the experimental part. Adapted from refs. [37-
38]. 
PRELIMINARY 
PLANNING 
  
• Verification of directed 
capillary flow phenomenon 
 
• Finding of suitable 
antigen-antibody model 
system 
 
• Initial tests with SU-8 on 
antibody immobilization 
SYSTEM-
SETUP 
• Antibody immobilization 
with small SU-8 substrates 
 
• Optimization of 
immobilization concepts 
and all the parameters 
 
• Design of the microfluidic 
immunoassay on the basis 
of the results from the 
small SU-8 substrates 
 
PROOF-OF-
CONSEPT 
• Actual testing of 
microfluidic  
immunoassay 
system with 
optimized 
immobilization 
concept and 
parameters 
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2 Microfluidics and wetting 
The evolution of microfluidics started in the early 1950s when first demonstrations of inkjet 
nozzles and liquid analysis at high precision by chromatographic systems were developed [2]. 
However, it took more than three decades before the real benefits of microfluidics, especially in 
improving the analytical performance, were discovered and it evolved to a discipline of its own: 
a discipline, which combines different branches of science in order to manipulate the fluid flow 
and analyse the components of a solution in the micro scale channels. The turning point can be 
traced back to the early 1990s, when Manz et al. [39] introduced the concept of micro total 
analysis systems (uTAS) by combining sample processing and electrophoretic separation on the 
same micro sized glass chip. The evolution of the microfluidic technology in short is presented 
in figure 4.    
 
Figure 4. Evolution of the microfluidic technology within the past 60 years. From ref. [2]. 
 
Minituarization brings about substantial changes in the importance of different phenomena due 
to large surface-to-volume ratio (e.g. surface tension, flow profile and diffusion). This enables 
unique and useful phenomena not seen in the macro world, which are shown e.g. as the 
negligible effect of gravitational forces, fast diffusion, capillary action, self-cleaning surfaces of 
lotus leaves and the capability of small insects, like water springtails, to walk on water. In this 
chapter, we present the concept of microfluidics, explain the new features of liquid flow and 
elaborate key physical phenomena common for fluids at the micro scale.  
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2.1 Basics of microfluidics  
Microfluidics is a scientific discipline, where the interdisciplinary understanding of surfaces and 
fluid reactions, material properties of the channel and fundamentals of physics, material science, 
chemistry and biology are needed. Microfluidics aim to manipulate microlitre volumes of 
liquids (e.g. urine, blood, saliva, water) on micro sized channels either passively utilizing the 
capillary action arising from the large surface-to-volume ratio or actively using different 
components like pumps and valves.  
The term microfluidic channel usually indicates that at least two dimensions are in the micro 
scale. Typically they are the depth and width of the channel, while the length of the channel can 
be in the millimetre or centimetre range. For example, an extraction channel in a SU-8 based 
capillary-electrophoresis chip has a length of 5 cm, width of 10 µm and depth of 50 µm [40]. 
Due to the micro sized diameter, the liquid flow is almost always laminar. Reynolds number is 
defined as (1),  
  𝑅𝑅 =  𝜌𝜌𝐷ℎ
𝜂
    (1) 
where ρ is the fluid density, υ the characteristic velocity of the fluid, Dh the channel diameter 
and η the fluid viscosity. The Re-values below 2000 indicate laminar flow. Laminar flow 
enables two or more streams to proceed without turbulent mixing in the microfluidic channel 
leading to a controlled flow profile. In laminar flow the mixing is dominated by diffusion. It is a 
fast process on microsystems as the diffusion distance d is squared in equation (2),  
  𝑑2 = 2𝐷𝐷    (2) 
where t is time and D the characteristic diffusion coefficient. The effect of gravity can be 
neglected in microfluidic channels, because surface tension is dominating. The relationship of 
gravitational forces and surface tension is described with Bond number (3),  
  𝐵𝐵 =  𝜌𝜌𝐿2
𝛾
    (3) 
where ρ is the fluid density, g the acceleration of gravity, L a characteristic length scale (e.g. 
diameter of the channel) and γ the surface tension. A typical value of Bond number for micro 
sized channel is below 1, because L is in its maximum gets values in centimetre scale (L < 10-2 
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m). Another dimensionless number related to the microfluidics is Capillary number (4), which 
describes the relative strength of viscosity and surface tension  
  𝐶𝐶 =  𝜂𝜌
𝛾
    (4) 
where η is the fluid viscosity, v the characteristic velocity of the fluid and γ the surface tension. 
A typical value for microfluidic systems is of order of 10-2 [41].  
2.2 Surface free energy 
Surface free energy, which in liquid-vapor systems is called surface tension, rise from the 
dissimilar forces the bulk and the surface molecules of the liquid experience. A molecule within 
the bulk of the liquid is surrounded in all directions by neighboring molecules. Cohesive 
interactions between liquid molecules, which are either hydrogen bonds or Van der Waals forces 
[42, p. 8], are balanced, yielding no net force. At the surface, the molecule is lacking upper 
counterparts resulting in increased potential energy compared to the bulk molecules. The 
interaction, which interfacial liquid molecules are experiencing, is greater between the 
underlying liquid molecules compared to the air molecules. Therefore, the interfacial liquid 
molecules are pulled towards the bulk. Surface tension, γ, is the work, which is needed to move 
molecules from the bulk to the surface. Surface tension (5) is calculated by the ratio of the 
change in free energy (dG) and the area (dA) in the surface  
  𝛾 =  𝑑𝑑
𝑑𝑑
    (5) 
Usually surface tensions for liquids are in the range of 20-80 mN/m. For example, the surface 
tension of water is 71.99 mN/m and methanol 22.07 mN/m (25°C)). [42, p.7] Optical 
goniometer and experimental methods, like Wilhelmy plate and Du-Noüy ring, are applied to 
measure the surface tension [42, p.15-16].  
2.3 Wetting 
Wetting, the ability of liquids to form interfaces with solid structures, is a characteristic property 
for the material surface in solid-liquid-vapor systems. It is governed by the combination of 
material's inherent chemical nature and topographic properties [43]. Three-phase system creates 
a contact line (wetting line), where all the phases are in contact. Contact angle, which 
determines the wetting behavior of the surface, results from the interfacial surface tensions 
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between liquid and solid, which are surrounded by vapor (figure 5). Wetting is described 
quantitatively by Young’s equation (6)  
  𝑦𝑦𝐵𝑦𝑦 =  𝛾𝑆𝑆 − 𝛾𝑆𝐿   (6) 
 where γ is the liquid surface tension, θ the contact angle, γSV the solid surface free energy and 
γSL the solid / liquid interfacial free energy [42, p.125].  
 
 
 
Figure 5. Contact angle in a three-phase system. From ref. [44]. 
 
Surfaces are either hydrophilic (wetting surfaces) or hydrophobic (nonwetting surfaces) 
depending on the measured contact angle. Contact angles between 0° and 90° result in 
hydrophilic whereas angles varying from 90° to 150° are hydrophobic surfaces [45]. The 
extreme contact angles, θ = 0° and 150° < θ < 180° yield superhydrophilic and –hydrophobic 
surfaces, respectively. Also prefix ultra, instead of super is sometimes applied [46]. These 
surfaces, often found in the nature [45], offer interesting properties, which have many potential 
application fields in the modern world. For example, lotus leaf – like superhydrophobic surface, 
is water-repellent and capable of self-cleaning [47]. Lee et al. [47] succeeded to mimic the lotus 
leaf structure by patterning the PDMS with micro- and nano-scaled grass via electroformed 
nickel (Ni) mould. The resulting contact angle of 163° of PDMS surface was close to the real 
lotus leaf contact angle (168°), even though they did not reach the perfect replication fidelity. 
The variation in wetting phenomenon is illustrated in figure 6. 
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Figure 6. Behaviour of the droplet on different wetting surfaces. 
 
A common method to measure contact angle is the sessile drop method [42, p.133], where the 
droplet is placed on the substrate and evaluated optically via goniometer and by fitting the 
droplet shape to Young-Laplace equation. Interactions at the boundary surface (e.g. evaporation 
of the liquid, chemical reactions between the solid and the liquid, adsorption of molecules from 
the solution, desorption of molecules from the surface, surface heterogeneity (chemical and 
structural) [42, p. 136-137]) cause hysteresis in the contact angle. Therefore, the thermodynamic 
equilibrium (Young’s contact angle), is only applicable in ideal cases, where the surface is 
presumed to be perfectly smooth, flat and homogenous. With real cases, the contact angle is 
defined by advancing (θa) and receding (θr) contact angles, where the advancing and receding 
angles refer to the movement of the wetting line. The phenomenon is called contact angle 
hysteresis (H) (7) and it is defined as the difference between advancing and receding angles 
 
  𝐻 =  𝑦𝑎 − 𝑦𝑟   (7) 
Surface roughness, either accidental (e.g. contaminations on the surface) or intentional (e.g. 
micro or nano patterning), results in situation, where Young’s equation needs additional 
modifications to assess the proper contact angle between the surface and the liquid [48]. With 
rough surfaces, where the entire area under the droplet is wetted, Wenzel model (8) is used  
  𝑦𝐵𝑦𝑊 = 𝑟𝑦𝐵𝑦𝑦   (8) 
where θw is the contact angle of the liquid on the rough surface and r the ratio (r 1) between the 
actual area of rough surface and the geometrically projected area and θ the Young’s angle of the 
liquid with corresponding flat surface with the same chemical characteristics. Wenzel model 
results in enhanced intrinsic contact angle with respect to the ratio r [42, p.137]. In case of rough 
≥
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hydrophobic surfaces, where air pockets are trapped under the droplet, Cassie-Baxter model (9), 
originally developed for chemically heterogenous surfaces, is used  
  𝑦𝐵𝑦𝑦𝐶𝐶 =  𝑓𝑠[𝑦𝐵𝑦𝑦 + 1] − 1  (9) 
 
where θCB is the contact angle of the liquid droplet on the rough surface and fs (> 1) the fraction 
of the solid surface on which the liquid is lying. The trapped air between adjacent patterns 
enhances the water repellency since the droplet is partially on air, thereby leading to liquid / 
solid and liquid / vapor interfaces [47]. Wettability is lowered and hydrophobicity increased. 
Both above described models apply only when the droplet size is sufficiently large compared to 
the surface roughness scale. 
Caputo et al. [43] were able to switch the wetting mechanism from Cassie-Baxter to Wenzel 
model by changing the inter-pillar spacing from 14 µm to 77 µm. Pillars were 42 µm x 42 µm in 
width and 25 µm in height. Phenomenon was reported to occur mainly due to the gravitational 
forces, which become larger than the interfacial tension force between air and water during the 
experiment. Therefore, the water is able to seep between the pillars with larger inter-pillar 
spacing. The threshold value for the change was reported to be 20 µm. Contact angles were 
ranging from 118° to 82° with spacing 14 µm to 77 µm, respectively. The state between two 
previously described models is suggested to be the intermediate state, where the liquid seeps 
only partly between the adjacent pillar structures [47]. It is called as Cassie-Wenzel state. 
Wenzel, Cassie-Baxter and Cassie-Wenzel models are illustrated in figure 7.  
 
 
Figure 7. Contact angle on rough surfaces is determined by Wenzel, Cassie-Baxter or Cassie-
Wenzel models. From ref. [47]. 
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In addition to surface roughness, wettability can be controlled by using different coatings. For 
example techniques like fluoropolymer coating, which increase the contact angle of oxidized 
silicon nanograss surface from 0° to 170° [46], different surface modifying techniques (e.g. 
oxygen plasma treatment, which lowers the contact angle of SU-8 e.g. from 68° to 27° [37]), 
electrostatic force (e.g. the electrostatic actuator made out of copper/PDMS composite polymer 
membrane changed contact angle from 152° to 131° by applied 250 V electrical potential [48]) 
and UV-light exposure (e.g. titanium dioxide (TiO2)-covered SU-8 surfaces change the contact 
angle from hydrophobic to hydrophilic upon induction to UV-light and return to hydrophobic 
with dark restoring conditions [43]) are used. 
2.4 Capillary phenomenon 
Capillary phenomenon, also known as capillarity, means the spontaneous filling of micro scale 
channels based on surface free energy minimization and wetting phenomena. It depends on the 
relative strength of the intermolecular attraction (occur between the liquid molecules and the 
solid material) and cohesive forces (occur between liquid molecules). Depending on the solid 
surface properties, nonwetting or wetting, the two-phase interface either forms a proceeding 
characteristic convex or concave meniscus, respectively. 
Capillarity is often demonstrated by putting a narrow glass tube called a capillary on a bowl 
containing liquid (e.g. water). Due to large surface area and inherently higher pressure inside the 
capillary compared to the outside, liquid can climb in a capillary tube for centimetres without 
any external power source. Capillary or Laplace pressure, the pressure difference between the 
two-phase interphase (air-liquid) is calculated from Laplace equation (10)  
  ∆𝑃 =  𝛾 � 1
𝑅1
+ 1
𝑅2
�   (10) 
where R1 and R2 are radii of curvature and γ the surface tension of the liquid. R1 is the meniscus 
radius and R2 the radius of the meniscus in the orthogonal plane. Surface tension minimizes the 
area of free surface yielding applied force F according to equation (11) 
  𝐹 =  𝛾𝛾 =  𝛾(2𝜋𝑟)   (11) 
where L is the distance the tension is forced to push the liquid forward and γ the surface tension 
of the liquid. Gravitational force Fg pulls the liquid column downwards. The total weight of the 
liquid column (12) in a cylindrical tube is the product of mass and gravity,  
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  𝑤 = 𝑀𝑀 =  𝜌𝜌𝑀 =  𝜌𝑀𝜋𝑟2ℎ  (12) 
where ρ is the density of the liquid, g is the gravitational coefficient, h the height of the liquid 
column and r the radius of the tube. At the equilibrium, the forces needed to support the liquid 
column and to minimize the surface tension are equal yielding the height (13) the liquid 
proceeds in the cylindrical tube   
  ℎ =  2𝛾𝛾𝛾𝑠𝛾
𝜌𝜌𝑟
    (13) 
Fluid flow in the microfluidic channel is determined by the channel design and surface 
properties [49]. Jokinen et al. [37] reported directed capillary flow by the topographic 
modification of the channel structure. They fabricated a double channel structure made out of 
SU-8, which was oxygen plasma treated and patterned with rows of triangles (base 20 µm, 
length 80 µm, inter-triangle distance 5 µm and thickness 12.8 µm) (figure 8). The triangles were 
placed either base or tip towards the liquid reservoir. They were able to show, that with a contact 
angle of 39° and inter-row distance of 11 µm and 14 µm, the water proceeded only in the 
channel, where the triangles were tips first. This is mainly explained by the fact, the proceeding 
meniscus gets a better support from the adjacent bases, which form an almost uniform wall 
whereas the tips offer a less hydrophilic support.  
 
 
Figure 8. The theoretical and experimental reach of directional wetting with fabricated test 
structures (on left). The advancing meniscus is supported by the wall structure the bases of the 
triangles form whereas the adjacent tips are not able to offer a suitable support for the meniscus 
(on right). From ref. [37]. 
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3 Thick photoresist SU-8  
SU-8 is an epoxy-based thermoset photopolymer, which was invented in the late 1980s by IBM 
[50] as a high-resolution resist for submicron lithography. It offered an alternative solution for 
x-ray lithography step in the high-aspect ratio process called LIGA [German acronym for 
Lithographie, Galvanoformung, Abformung (Lithography, Electroplating and Molding)], which 
was unconvenient due to relatively high cost and limited access to synchrotron X-ray equipment 
[51]. Later on, the outstanding material properties of SU-8 and compatibility with conventional 
methods in microfabrication assisted the evolution from simple patterning material to a material 
of choice with structural components, especially in microfluidic MEMS applications [33, 52]. In 
this chapter we present the basics of SU-8 structure, properties, fabrication and modification 
prospects.  
3.1 Structure 
SU-8 is a negative photoresist, which monomer contains eight free epoxy groups (figure 9). It is 
based on multifunctional bisphenol A novolak epoxy resin (EPON® SU-8 resin, Shell 
Chemical) where the photoacid generator (PAG), a mixture of triarylsulfonium salts of 
hexafluoroantimonate (SbF6-) (CYRACURE® UVI, Union Carbide), is mixed in a 
concentration of 10 w-% [53]. The original solvent in SU-8 formulations was γ-butyrolactone 
(GBL), but for later products, it was replaced by cyclopentanone. The alteration offered 
improved coating quality, adhesion properties and faster processing times [53]. The resin-
solvent ratio is one of the most important properties of SU-8 as it defines the material viscosity 
and obtainable layer depths [52-53].  
 
Figure 9. Molecular structure of SU-8 monomer. From ref. [30]. 
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The high chemical and thermal resistance as well as good mechanical properties are based on 
the cross-linking of eight free epoxy groups. The cross-linking is initiated by UV-light 
exposure, which transforms the photoinitiator into hexafluoroantimonic acid. During post-
exposure bake, formed strong acid catalyses the cationic ring-opening photo-polymerization 
reaction, which increases the molecular weight and diminishes the solubility of UV-exposed 
parts. This yields designed patterns in resist film upon development. [53-54] 
SU-8 is commercially available from MicroChem Inc [55], which sells various blends of SU-8. 
The compositions of three different blends are illustrated in table 1. By diluting the 
commercially available blends, new formulations are obtained.   
 
Table 1. The composition of SU-8 50, 100 and 2000 formulations. From ref. [56-57].  
COMPONENT SU-8 50 (wt-%) 
SU-8 100 
(wt-%) 
SU-8 2002 
(wt-%) 
Resin 69 73 29 
Solvent 30-35 20-30 65 
SbF6 (photoinitiator) 3,3 3,5 1,4 
Viscosity (cSt) 12250 51500 7,5 
 
3.2 Fabrication of SU-8 layer 
SU-8 layer fabrication follows the five-step photolithographic process common for all negative 
photoresists: spin-coating, soft-bake (SB), exposure, post-exposure bake (PEB) and 
development steps (figure 10, table 2). The process results coatings with low surface roughness 
[58-59] and layer depths varying from 750 nm [52] up to 500 µm [60] depending on the blend 
viscosity. The exposure by UV limits the minimal feature size to submicron level, because 
feature size is dependent on the diffraction of the light. Process parameters are optimized for the 
equipment on the basis of the blend manufacture's reference values. According to a three-level 
L9 orthogonal-array based Taguchi method the most critical step is the soft bake, at least when 
good resolution and aspect ratio are desired [61]. The significance of development time as well 
as exposure dose, increase with the thicker layer depths.   
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Figure 10. The process flow for a single-layer coating of negative photoresists SU-8.  
 
Table 2. Experimental values for fabrication parameters of layer thicknesses of 20 and 50 µm. 
FABRICATION 
PARAMETER 20 µm 50 µm 
Spincoating 9000 rpm 3000 rpm 
Soft bake (65°C + 95°C) 5 + 8 min 5 + 15 min 
UV-exposure 12 s 16 s 
Post-exposure bake (95°C) 8 min 15 min 
Development 5-10 min 10+ min 
 
SU-8 layer is fabricated most often on top of a dehydrated silicon (Si) substrate. The 
dehydration (for example a 40 min bake in 200°C oven [60]) removes the excess moisture 
bounded to silicon, which could cause bubbling and uneven film forming during the SB. Spin-
coating is performed in a two-step process where first a low speed (500 rpm) step spreads the 
resists evenly to the whole wafer surface, while higher speeds (1000-9000 rpm) are used to 
adjust the thickness. The parameters (spin speed and time) are determined on the basis of 
material viscosity. The higher the viscosity is, the higher spin speeds and times are needed to 
obtain thinner layers as can be seen from the spin speed curve shown in figure 11. A specific 
problem of spin-coating is the edge bead effect, which is known as the accumulation of the 
Si
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resist material on the edges of layers. This is emphasized especially with more viscous SU-8 
blends [53].   
  
Figure 11. Spin speed curves for different SU-8 blends. The low viscosity material enables 
uniform coatings, defect and stress free layers as well as easy removal of unsolidified resin 
during development (e.g. SU-8 25). High viscosity is desirable when reduced lateral flow and 
the construction of stable and thick resist films are wanted (e.g. SU-8 100). [53] From ref. [55]. 
 
Soft bake is a diffusion-controlled process where excess solvent is evaporated away from the 
coated resist layer by baking the wafer on a flat-plane hotplate. Horizontal placement prevents 
the freshly spin-coated layer from flowing due to gravitation forces [62]. The hotplate is 
possible to replace with oven, but the ambient heat distribution ovens have, produces easily a 
skin-like layer to SU-8 surface hindering the pattern transfer later on [53]. The SB is performed 
using ramped temperature profiles to prevent the formation of residual stresses, which can cause 
cracking and wafer bowing [62]. Temperature is increased progressively from room temperature 
(RT) to close to 65°C and then up to 95°C. Baking times depend on the layer thickness. Higher 
temperatures than 95°C are not recommended as they increase the risk of crack formation [50]. 
In addition to solvent evaporation, the SB smoothens the edge bead effect and improves the 
adhesion of SU-8 to underlying Si [53]. Commercially available primers, OmniCoat and HMDS 
[53], can be used to enhance the adhesion.   
After being cooled down to RT, the resist film is exposed to UV-light. Recommended 
wavelength is (mercury i-line) 365 nm [55]. Exposure time is optimized because too short times 
produce cracks [62] and too long times rounded edges [53]. If the resist layer is non-uniform 
either due to edge bead formation or uneven baking place, the diffraction effect, which is caused 
by Fresnell diffraction, takes place during the exposure step [53, 63] (figure 12). The 
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phenomenon is responsible for pattern enlargement especially near the edges of the photomask. 
The top parts of structures are exposed to higher dose of UV-light therefore leading to T-like 
profiles shown in figure 12. Diffraction error is especially emphasized with thicker films where 
thickness non-uniformity can be high. In a bad situation, the error in layer thickness can range 
from 30 to 100 µm when 0,1 to 1 mm coatings are made [63]. One solution is to use index 
match materials between the photomask and the film to compensate the air gap. With SU-8 no 
appreciable error was found when glycerol was used whereas the exposure without glycerol 
resulted in a pattern width error as high as 45 % [63].  
 
Figure 12. The effect of diffraction to the UV-light intensity profile in contact-based 
photolithography (on left). The T-like profiles in lithographically patterned structures are 
encountered due to thickness non-uniformity during the exposure step (on right). From ref. [63]. 
 
Post-exposure bake (PEB) takes place shortly after UV-exposure in order to limit the PAG 
diffusion from the polymer layer, which could hinder the cross-linking capability of the 
photopolymer [50]. In contrast to soft bake, no ramped profile is used which accelerate the 
cross-linking process [60]. Baking temperature is 95°C and baking time chosen by the layer 
thickness. The cross-linking process continues until the glass transition temperature (Tg) of the 
cross-linked SU-8 becomes close to the baking temperature [54].  
After PEB, un-cross-linked areas are removed by developing the substrate at RT in propylene 
glycol methyl ether acetate (PGMEA) [53]. Agitation enhances the development but only gentle 
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approach should be used to prevent the destruction of fragile structures  [62]. Development step 
might also cause minor pattern enlargement, because negative photoresists are prone to absorb 
organic solvents [63]. The development step also reveals fabrication induced residual stresses as 
a structural deformations and crack-like distortions, which lead to leakages in microfluidic 
systems as well as unwanted scattering and increased propagation loss in optical systems [50].  
An extra step of a high temperature hard bake (HB) can be applied to diminish the amount of 
cracks. Besides reduction in the crack amount, HB at 200°C for 30 min improves the resistance 
of SU-8 towards most metal etches and solvents (e.g. nitric acid, sodium hydroxide (pH 13) at 
90°C, ammonium fluoride-hydrofluoric acid and ferric chloride) [52]. 
Multi-layer coatings of SU-8 are obtained by repeating previously mentioned steps. The layers 
can be fabricated without separate PGMEA treatment [62]. Figure 13 presents a multi-layer SU-
8 structure of six layers where only one development step is used. The lack of excess 
development steps accelerates the fabrication process, hinders the possibility of formation of 
unwanted cracks and reduces the probability of swelling due to PGMEA. Also the feature 
complexity and coating uniformity are enhanced. With multi-layer coatings thicknesses up to 
over 1 mm are obtained [51]. 
 
 
Figure 13. Up to six layers of SU-8 have been fabricated by using only a single development 
step at the end of the whole fabrication process. The numbers refer to fabrication order. Slight 
distortions are caused by the overlapping of various photomasks. From ref. [62].  
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3.3 Native SU-8 properties 
Table 3 represents the material properties of SU-8. Given values are suggestive as properties are 
highly sensitive towards processing conditions [54] and selection of the solvent [64]. 
 Table 3. Native properties of SU-8 50. Unless otherwise mentioned, the used solvent is GBL.  
PROPERTY SU-8 
MECHANICAL Young’s modulus, E (GPa) 3.2 ± 0.2 
4.95 ± 0.42 
5.9 ± 0.9 
[65] 
[66] 
[65] 
Shear modulus, G (GPa) 0.3 
1.2 ± 0.4 
[65] 
[65] 
Max stress, σtot (MPa) 12 
34 
[54] 
[66] 
Friction coefficient, µ 0.19 [52] 
Poisson ratio, υ   0.29 ± 0.02 
0.33 ± 0.02 
[65] 
[65] 
Biaxial modulus of elasticity, E/(v-1), (GPa) 5.18 ± 0.89 [67] 
Elongation at break (%) ~ 7.5 [54] 
Bond strenght (MPa)  Silicon (Si) 18.5 ± 4.6 (cyclop.) [64] 
Gold (Au) 4.8 ± 1.2 (cyclop.) [64] 
PHYSICAL Glass transition temp. (un-cross-linked), Tg (°C) 49.5 [54] 
Glass transition temp. (cross-linked), Tg (°C) max 238 [54] 
Decomposition temp., TD (°C) > 340 [54] 
Thermal expansion coefficient, CTE (10-6/°C) 52 ± 5.1 
102 
278 ± 31 
[67] 
[54] 
[65] 
Thermal conductivity, κ (W/mK) 0.208 ± 0.035 [68] 
Viscosity, η (cSt) 12250 [56] 
Density, ρ (SU-8 50, kg/m3) 1219 [56] 
ELECTRICAL Refractive index, n (600nm) ~ 1.595 [69] 
Dielectric constant (30 GHz), εr  3.25 [70] 
Dielectric loss (30 GHz) 0.027 [70] 
OTHER Contact angle, θ (°) 
 
Surface energy, γ (mNm-1) 
74 
90 (cyclop.) 
45.20  
26.48 (cyclop.) 
[58] 
[58] 
[58] 
[58] 
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Low Young’s modulus combined with typical Poisson ratio for polymeric materials offer high 
compliance for micromechanical structures. Lithographically fabricated structures are 
mechanically stable and durable, and also inert towards various acids and bases often used in 
microfabrication [50]. Nowadays the aspect ratio (AR) around 20 is common [51-52, 61-63, 
67], but careful optimization of fabrication process yields also higher ARs [61].  
Relative high residual stresses (tensile stresses) on SU-8 coatings are built up during the 
fabrication and revealed during the development step as crack like distortions as already 
mentioned in the subchapter 3.2 [50]. Longer PEB times increase the stress (stress is 30 MPa 
with 5h PEB, but only 12 MPa with 30 min PEB) [54]. In addition, the environmental humidity 
has an effect on the stress of SU-8 layer, which is however reversible [54]. Besides the 
processing conditions, also the mismatch between thermal expansion coefficients (CTE) of 
silicon (2,6 x 10-6 /°C) [71, p.84] and SU-8 (52 x 10-6 /°C) induces tensile stress formation [51]. 
The large range of given CTE values for SU-8 (in table 3) originates from the assumption, 
which has been done, to make the measurement and calculations easier. Material is assumed to 
be isotropic to all directions even though the thickness and planar directions properties are not 
identical [54]. Therefore the measurements in out-of-plane direction give significantly higher 
CTE value for SU-8 [54]. Also the values for Young’s modulus, shear modulus and Poisson 
ratio are affected [65]. 
Another problematic feature of SU-8 formulation as an organic material is the poor adhesion to 
most inorganic materials like glass, silicon dioxide (SiO2) and gold [32, 64]. A better adhesion 
is observed with silicon nitride [32]. In addition to the solvent, various adhesion promoters and 
increase in exposure dosage, to a certain point, can improve the adhesion between SU-8 and the 
substrate [64]. SU-8 has high thermal stability compared to other thermosets like PEs [72]. It is 
an excellent electrical insulator and possible material for optical waveguides, due to relatively 
low refractive index [69]. In addition, SU-8 is optically transparent above 360 nm (figure 14).  
Typical for polymeric materials, also SU-8 is known to be highly autofluorescent at least at 
emission wavelengths of FITC (fluorescein isothiocyanate) and Cy3 (red fluorescent dye of the 
cyanine dye family) [59]. Because fluorescence is the most used detection method among 
biological samples [3], this has to be taken into account while designing BioMEMS 
applications. The problem can be overcome by labelling the biomolecule under use e.g. with 
Alexa Fluor 647 - tag, which emits UV-light with higher emission wavelengths [30]. Other way 
to reduce the autofluorescence property is to decrease the layer depth. A 0.8 μm thick SU-8 
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layer has 20 % higher background fluorescence compared to standard glass plates while the 
value is 400 % with 12 μm thick layers [59]. 
 
 
Figure 14. Absorption graph of photoresist materials: SU-8 (A), dry photoresist Riston® (B) 
and positive diazo resist (C). Compared to other photoresist materials, SU-8 absorbs 
significantly less UV-light. From ref. [73].  
 
Post-exposure baked SU-8 layer is highly hydrophobic (contact angle around 75°) and has a low 
surface energy [58]. The contact angle is increased while different solvent is used in SU-8 
formulation. The values are around 86-90° with cyclopentanone [74, 58]. 
SU-8 has sufficient biocompatibility and reduced biofouling properties, which enable its use in 
biomedical applications [29]. Nevertheless the observed mechanical delamination initiated 
especially at the corners of microfluidic devices might be a problem when using SU-8 in in vivo 
/ vitro devices [29]. Problematic features are also the fairly poor hemocompatibility compared to 
polyurethane controls [75] and ability to not be able to support the growth of most eukaryotic 
cells [30]. At least with primary neuronal cultures, the reason for incapability was reported to be 
toxic leaching from the PAG (small amount of released antimony and fluorine detected) and 
improper ability to sustain neuronal adhesion [76]. Cytocompatibility can be increased by post-
processing strategies, which include combinations of hard bake, isopropanol (IPA) sonication 
and oxygen plasma and parylene coatings [76].  
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3.4 Modification of SU-8 
Native SU-8 surface is highly hydrophobic, which is not the ideal case with bio applications, 
because hydrophobic surface enhances biofouling, limits cell attachment and prevents the 
covalent biomolecule immobilization among other limitations [77]. Therefore most of the 
surface modification methods, both wet and dry methods, concentrate on enhancing the SU-8 
surface hydrophilicity [60]. Bulk modification comprises usually boosting of electrical and 
magnetic properties of SU-8. Compared to the other polymeric materials common for 
microfluidics, e.g. PDMS, the modification of SU-8 has not had that much attention [78]. 
3.4.1 Wet surface modification 
Most of the wet modification methods are based on the cleavage of the residual epoxy groups 
the surface has after curing process [31-33]. Cyclic epoxy groups are cleaved to reactive C-O 
bonds with different acid or alkali solutions. The formed C-O bond is highly reactive due to one 
extra free electron pair. It acts as a nucleophile in the following oxidation reaction donating the 
free electrons and converting into two hydroxyl groups. By treating the hydroxyl groups with 
suitable chemicals, in an adequate chemical environment, desired functional groups are possible 
to yield onto SU-8 surface.   
In aminosilanization, the SU-8 surface is functionalized by amine groups (-NH2). Residual 
epoxy groups are converted to hydroxyl groups by treating the surface with cerium ammonium 
nitrate (CAN) for 30 min [31] or with strong sulphocromic solution for 10 min [32]. By 
incubating aminopropyltriethoxysilane (APTES) for 1 h with former [31] and [3-(2-
aminoethyl)aminopropyl]-trimethoxysilane (AEAPS) for 7 min [32] with the latter, the 
hydroxyl groups on the SU-8 surface react with silane groups, yielding free amine groups 
towards the solution phase (figure 15). Similarly, carboxyl acid groups (-COOH) are obtained 
on to the SU-8 surface after oxidation reaction with glycine or 11-mercapto undecanoic acid 
(MUA) for 2 h [33].  
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Figure 15. The CAN treatment converts the residual epoxy groups to more reactive hydroxyl 
groups in an oxidation reaction. The amine groups are formed by surface aminosilanization with 
APTES. From ref. [31]. 
 
Another common modification process is the graft polymerization with the help of UV light [77, 
79]. Grafting process is based on the creation of reactive species like radicals on SU-8 surface, 
which can form covalent bonds between monomers. Grafted monomers serve as an initiation 
site for free radical polymerization reaction upon UV-light irradiation. One advantage of UV-
mediated grafting is the possibility to pattern the grafted polymer with the help of photomask, 
just like the standard SU-8 patterning is done [77, 79]. Figure 16 presents the UV-mediated 
grafting process where SU-8 surface is covered with polymer.  
 
 
Figure 16. UV-mediated graft polymerization is composed of hydrogen abstraction step, where 
the free radical is produced to surface, and surface grafting step, where the monomer is bonded 
covalently to SU-8 surface via UV-light.  From ref. [77].  
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Depending on the amount of residual photoacid generator, there are two approaches to grafting 
process. In the first scenario, the freshly fabricated SU-8 layer contains some residual photoacid 
generator, which can be used as initiator sites for the grafting process. UV-mediated grafting is 
executed by simply covering the SU-8 surface with wanted monomer solution and exposing to 
UV-light. For example, 10 wt-% acrylic acid solution forms grafted poly(acrylic acid) (PAA) on 
SU-8 surface after 10 min UV-exposure [77]. Surface coverage is directly proportional to the 
amount of photoacid generator on the surface. Also PEG and poly(acrylamide) (PAM) coatings 
are possible with the similar process [77].  
If the fabrication process has decomposed most of the photoacid generator (the second 
scenario), additional photoiniator is bounded to the surface as initiator sites. By irradiating a 
photoinitiator covered surface with UV-light, free radicals are formed, which are capable of 
initiating the polymerization reaction. After this, the graft polymerization is performed as 
explained previously. For instance, hydrogels like 2-hydroxyethylmethacrylate-based (HEMA) 
hydrogels can be grafted on SU-8 using 1-hydroxycyclohexyl phenyl ketone (HCPK) as a 
surface-bound initiator [79].  
Graft polymerization is also possible to perform without UV-exposure. Free radicals are 
produced by using catalyst containing solutions in cleaving and grafting steps. After the residual 
epoxy groups are oxidized to hydroxyl groups, catalyst, like cerium (IV) converts the hydroxyl 
groups to free radicals [30]. Free radicals react further with the solution yielding functional 
groups for grating. For instance, CAN + nitric acid or CAN + sulphuric acid solutions can be 
used to graft PAM or PAA polymers, respectively, on SU-8 surface. 
With some bio applications, more hydrophobic SU-8 surface than native is beneficial. An 
example of this is the segmented flow operation microfluidic device, which is used to transfer 
small volume droplets in the channel without losing their droplet shape. This kind of approach 
is applicable e.g. to yeast suspension [74]. The walls of SU-8 channel yield contact angle close 
to 130° by using 10 min piranha solution (sulphuric acid hydrogen peroxide) treatment 
combined with 12 h octadecyltrichlorisilane solution (ODTS) soak [74].  
3.4.2  Dry modification  
Dry surface modification methods do not use harsh chemicals, which prevent the retention of 
toxic residues and the destruction of microstructures in the underlying substrate (e.g. SU-8). 
These processes are therefore considered better suited for biomolecule containing devices. [28] 
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Oxygen plasma treatment is a popular method to render all kinds of polymeric materials more 
hydrophilic [80]. The reduction in contact angle is adjusted by the plasma dose and treatment 
time. The higher the dose and the longer the time, the more notable change in hydrophilicity is 
obtained [80]. Treatment time can be in s or in min. For example, the 8 s treatment time (applied 
pressure: 2.7x10-4 bar, plasma power: 600 W) yields a contact angle of 25.6° [80] and a 2 min 
treatment (applied pressure: 2x10-4 bar, plasma power: 50 W, potential: 0.8 V and oxygen flow: 
36 sccm) smaller than 5° contact angles [58]. The downside of oxygen plasma treatment is the 
quite fast hydrophobic recovery the contact angle experiences after storage. Recovery is 
dependent on the used plasma dose and time, longer times and higher doses yielding more 
stable surfaces [58]. Another problematic feature is the small amount of released antimony 
during the treatment [76, 80]. Because antimony is slightly toxic, this might be a problem while 
biological applications are under consideration. 
Another well-known dry modification method is the pyrolytic dissociation of ammonia, which 
functionalizes SU-8 surface with amine groups [28]. First the hot wire chemical vapour 
deposition (HWCVD) decomposes thermally the ammonia gas to amine groups and highly 
energetic hydrogen species. Released hydrogen species cleave the residual epoxy groups with 
their energy making a bonding place for the amine groups on the SU-8 surface.  
3.4.3 Bulk modification 
By bulk modification, SU-8 is turned into a nanocomposite material, which shares the good 
processing capabilities of polymers with improvements in e.g. magnetism and conductivity 
obtained by the added inorganic phase [81]. Inorganic phase is composed of inorganic materials 
in a nanopowder format. It is added to SU-8 resist before the five step photolithographic 
fabrication process by simply mixing. Together these two materials form a suspension, which 
needs hours of mixing. Sometimes mixing is assisted with ultrasound sonication [81-83]. The 
amount of agglomerization is diminished by addition of a surfactant. This enhances the 
nanoparticles to distribute evenly in the SU-8 blend. To make SU-8 magnetic materials such as 
nickel (Ni) particles (approximately 100 nm in diameter) [84-85], ferromagnetic dopants [86], 
superparamagnetic magnetite nanoparticles [81, 83] or colloidal ferric oxide nanocrystals [82] 
have been added to SU-8 blend.  
Similarly, improvement in electrical properties, like in conductivity, is obtained by dispersing 
silver (Ag) particles between 0.2 to 2.5 µm in size to SU-8 blend in a powder format [87]. 5-6 
30 
 
vol-% is enough to cause nanoparticle agglomeration, which acts as pathways for electrons 
leading to the increase in conductivity.  
In addition to alter the native SU-8 properties by forming a composite suspension, another form 
of bulk modification is to make SU-8 porous by adjusting the solvent content in the resin 
material. Solvent amount controls the pore size during the UV-exposure and cross-linking steps. 
For example pore sizes between 6-10 nm are obtained with solvent contents 55-85 wt-% [88]. 
Porous SU-8 is used for filtering purposes. This porosity is capable of filtering smaller than 70 
kDa molecules from a mixture of reagents [88].  
3.5 SU-8 imprinting 
Nanoimprint lithography (NIL) is a technique to fabricate nanosized structures onto the SU-8 
surface by combination of mechanical deformation and UV-light. Usually low viscosity blends 
of the SU-8 family are used (e.g. SU-8 2000 [13, 89] and 3000 [90]). The mould is either hard 
(e.g. silicon [91] or nickel [90]) or elastic (e.g. PDMS [13]) depending on the applied technique.   
As with standard photolithography, SU-8 is first spin-coated on a suitable substrate and soft 
baked. In conventional UV-NIL, the UV-exposure is applied through patterned quartz mould. 
The simultaneous UV-light and pressure transfer the patterns onto the SU-8 surface (figure 17). 
Patterns are finalized with the post-exposure bake. Another common UV-NIL version is the 
thermal assisted UV-NIL, where heating is incorporated into the imprint step (figure 17). The 
heating temperature should be above the Tg of un-cured SU-8, but below the soft-baking 
temperature in order to avoid the de-gassing effect [90]. UV-exposure is made either during [91] 
or after the imprint [13, 90]. In the latter case, an additional pre-UV-treatment is suggested to 
support the patterns from collapsing [90]. As was with the conventional UV-NIL, the patterns 
are finalized with baking. All the imprint parameters (temperature, pressure, exposure time etc.) 
depend greatly on the applied equipment and SU-8 layer depth. Therefore, only rough 
guidelines can be given for the parameter values. Egea et al. [13] fabricated nanoscale gratings 
onto the 800 nm thick SU-8 layer. Imprinting step (T = 90 °C, t = 2 min) with PDMS mould and 
the 30 s UV-exposure after demoulding yielded grooves of 225 nm in depth and 500 nm in 
width at a pitch of 1 µm. Thermal-assisted UV-NIL is also possible to do without commercial 
equipment [92]. The mould is simply placed by hand and pressed using extra weight at the end 
of the soft-bake step. The lack of vacuum in the mould placement caused bubbling, but it was 
not reported to have effect on the final structures. 
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Figure 17. The process flow of the thermal-assisted (a) and conventional (b) UV-NIL processes 
for SU-8. In thermal-assisted UV-NIL (a), the SU-8 surface is UV-exposed before imprinting 
step in order to control the formability. From ref. [90].  
 
Compared to the photolithography, NIL offers better resolution. Feature dimensions less than 10 
nm are enabled [93]. The major drawback of the NIL process is the characteristic residual layer, 
which is formed during the imprint process. An additional processing step (e.g. RIE-treatment) 
is needed to remove the excess resist. The UV-NIL process offers many variations from which 
examples are reversal UV-imprinting (SU-8 is spin-coated to the mould instead of the substrate 
[94]), negative UV-NIL (NUV-NIL) (the imprinted features are used for the alignment of the 
UV lithography, which makes possible to fabricate both the micro and nano sized structures 
simultaneously [89]) and combined-nanoimprint-and-photolithography (CNP) with hybrid fused 
silica-nickel mould (technique enables patterns without residual layer and with higher aspect 
ratio than the structures have on the mould [93]). 
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4 Antibodies 
Antibodies are a special group of glycoproteins called immunoglobulins (Ig), which are 
products of the B-lymphocyte cells of the mammalian immune system. They take part to a 
protective mechanism known as an adaptive part of humoral defense system by recognizing and 
destroying / neutralizing e.g. viral antigens noticed in the blood circulation. The system is 
mounted by white blood cells (both the B- and T-cell lymphocytes) and macrophages [95, 
p.1019-1020]. In human body, the antigen recognition and thereby the immunization process is 
actuated mainly by two immunoglobulin families: IgM and IgG [95, p.1022]. The primary 
immune response produces the low affinity IgM antibodies after infection. In the secondary 
phase, after the affinity maturation, the high affinity IgG antibodies are produced. Other 
immunoglobulin families have other functions in human body (summary in table 4).  
 
Table 4. Immunoglobulin types and their functions in human body. Adapted from ref. [95, 
p.1022-1023]. 
CLASS 
CONSTANT 
REGION 
STRUCTURE 
ROLE IN HUMAN 
BODY 
SERUM 
CONCENTRATI
ON 
(mg/ml) 
MASS 
(kD) 
HEAVY 
CHAIN 
STRUCTU
RE 
lgA Dimer 
First line of defense, 
external secretion 
3 
180-
500 
Α 
lgD Homodimer Task not known 0,1 175 Δ 
lgE Homodimer 
Protection against 
parasites, responsible 
for allergic reactions 
0,001 200 Ε 
lgG Homodimer Secondary response 12 150 Γ 
lgM Pentamer Primary response 1 950 Μ 
 
The ability of antibodies to form highly sensitive and specific binding with antigen molecules, 
has yielded an important bioanalytical tool, immunoassay. Since its discovery, the immunoassay 
has been under widespread use in diagnostics. The later developments in fabrication of both the 
engineered antibodies and the antibody libraries have only broaden the application field. This 
chapter describes the antibody structure and the basic principle of immunoassay and introduces 
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the concept of recombinant antigen binding fragment (Fab) and its production prospects through 
bacteria expression using phage display libraries. 
4.1 Antibody structure 
The molecular structure of immunoglobulin G consists of three almost equally sized functional 
recognition compartments. All together they form a structure resembling closely the shape of 
letter Y (figure 18). Two of these compartments, forming the tips of Y, are called antigen 
binding - sites, Fabs (F=fragment, ab=antigen binding), where the antigen recognition takes 
place. The third compartment, known as Fc (c=crystallization) forms the tail of Y. It is not used 
in the antigen binding process, but is important in other immunological reactions called effector 
functions (e.g. phagocytosis, natural killer cell activation and activation of the classical 
complement pathway [96]).  
 
 
Figure 18. The structure of lgG. Bonds marked with red are disulfide bonds.  
 
The tail and the tip are linked together by a hinge region, which is rich in proline (Pro), 
threonine (Thr) and serine (Ser) amino acids. Hinge region facilitates the movement of the 
different parts of the antibody molecule (flexibility is needed e.g. during the immunocomplex 
formation). It is highly prone to the proteolytic digestion of papain and pepsin molecules. These 
proteases digest the intact antibody into specific fragments: papain (pH 7.0) into two separate 
Fab fragments and a single Fc fragment and pepsin (pH 4.5) into a F(ab)2 fragment and partially 
digested Fc region denoted as pFc. [96]  
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In structural domain level the immunoglobulin G consists of two identical polypeptide chains 
called heavy (H) chains and two also identical light (L) chains. The name light and heavy refers 
to the sizes of the chains. Heavy chain contains ca 450 (45 kDa) and light 250 amino acids (25 
kDa), respectively [26]. Chains are linked together by disulfide bonds: two or more bonds 
between heavy chains and one bond between each heavy and light chain (marked as red in 
figure 18). Light chains have no physical connection between each other.  
The both polypeptide chains can further be divided to immunoglobulin domains known as 
constant (C) and variable (V) domains. Heavy chain contains three homologous constant 
domains (CH1, CH2 and CH3) and one variable (VH) domain. Light chain contains one constant 
(CL) and one variable domain (VL), respectively. The variable domains in both chains are called 
as amino(N)-terminal domains. They differ from one antibody to another and are responsible for 
the diversity of the specific antigen binding [26]. Compared to variable domains, constant 
domains are more similar between different antibodies belonging to the same family (listed in 
table 4).   
    
The domain structure of antibody adopts tertiary structure known as immunoglobulin fold [26]. 
It is consisted of a pair of antiparallel β-sheets, which are linked together by a disulfide bond 
and hydrophobic interactions. At both variable domains (VL and VH) the fold comprises six 
hypervariable loops from which H1, H2, H3 are found within the heavy chain variable domain 
and L1, L2, L3 within the light chain, respectively. Together these six hypervariable loops form 
the antigen-binding site, which is also called as complementary determining region (CDR) [95, 
p.1024]. The CDR is surrounded by four framework regions (FRs), which form a scaffold to the 
antigen binding loops. Antibodies belonging to the IgG family are bivalent [96], because there 
are two antigen-binding sites per one antibody molecule.  
Natural antibodies can be either monoclonal (MAbs) or polyclonal (PAbs) in nature depending 
on the amount of involved B-lymphocytes during the antibody production (after the recognition 
of viral antigen) [96]. PAbs are derived from multiple B-lymphocytes. They have multiple 
specificities and are therefore capable of binding to multiple different epitopes. This increases 
the immune protection. In contrast to PAbs, MAbs come from a single immune cell, thereby 
leading to always homogenous, well-defined and single epitope antibodies [96]. In addition, 
cultivated MAbs offer higher concentration and purity levels compared to the PAbs. A typical 
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concentration of a specific antibody in polyclonal sera is between 50 to 200 µg/mL whereas the 
MAbs offer 10-fold higher numbers in concentrations [96]. 
4.2 Antigen and antibody-antigen interactions 
Antigens are a versatile group of molecules ranging from proteins to carbohydrates. They elicit 
the recognition process by a specific structure called epitope (or antigenic determinant), which 
is identified by the CDR loops of the antibody. Epitope is usually only four to ten amino acids 
in size. The small size enables the adoption of multiple epitopes in one antigen leading to a 
multivalent antigen molecule. Hapten is a special kind of antigen as it is a small organic 
compound used as a whole in the recognition process. It is not capable of immunogenic activity 
without covalent conjugation to a larger protein structure [97, p. 718]. 
The bonds between epitope and antigen-binding site are non-covalent in nature. Forces like 
hydrogen and electrostatic bonds, Van der Waals forces and hydrophobic interactions are 
formed, which result in reversible binding [97, p. 137]. Each of these interactions alone is 
respectively 100 to 1000 times weaker than a covalent bond and occurs only over short distance. 
Interactions are also easily disrupted by high salt concentrations, extremes of pH, detergents and 
by the competition with high concentrations of the pure epitope itself [97, p. 137]. The 
complementary shape of the antibody and the epitope strengthens the bond. Also structural 
changes, which sometimes occur during the binding process, strengthen the bond [26]. The 
binding strength between a single antigen-binding site and its antigen is called affinity [96]. It is 
measured by equilibrium binding affinity constant Kd (13)   
  Ab+Ag 
kon
koff
↔ Ab-Ag 
  
yields
�⎯� Kd=
koff
kon
= [Ab][Ag]
�Ab-Ag�
   (13) 
where Ab is the concentration of the free antibody in the solution, Ag the concentration of the 
free antigen, Ab-Ag the concentration of antibody:antigen complex, kon the formation rate 
constant and koff the dissociation rate constant [26]. Kd is a thermodynamic property, which 
typically gets relatively low values of 10-5-10-11 mol/l [26]. Another term related to the binding 
process is avidity. It is described as the combined synergistic strength of individual bond 
affinities with bi- and multivalent antibodies [97, p. 129]. Avidity is also assay specific [96].   
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4.3 Immunoassay 
Immunoassay is a bioanalytical test to detect the concentrations of different substances from the 
solutions (e.g. saliva, blood, urine, lymph) by utilizing the specific binding capability the 
antibody and antigen have towards each other. There are two types of immunoassays: 
homogenous and heterogenous assays. In homogenous immunoassay, both the sample and the 
capture agent are in the same solution phase. All the reagents are placed simultaneously (one 
step assay) providing short analysis times, multiplexing capability as well as very fast 
electrophoretic separations. However, a separate pre-concentration step is often needed before 
electrophoresis. In heterogenous immunoassays, antibody is immobilized onto the substrate 
surface and the sample is in the solution phase. The immobilization step as a whole 
(immobilization surface, conditions and procedure) have an influence on the antibody, which 
makes it a very important step of the whole assay. The drawbacks of the heterogenous 
immunoassays are the several washing steps where unbounded reagents or analytes are rinsed as 
well as cognate mixing and separation steps which longer the performance time. [1, 3, 5] 
The most common format of heterogenous immunoassay is the enzyme-linked immunosorbent 
assay (ELISA) [15], where one of the immunoreagents is immobilized onto the 96-well 
microtiter plate. One assay component is conjugated with the enzyme (biological label), which 
reacts with the color forming substrate. The reaction is detected by colorimetric system through 
which the target analyte binding is quantified.  
The two most widely used ELISA assay formats are competitive and sandwich (also known as 
non-competitive) assay (figure 19). In competitive assays, the target analyte in the sample 
competes from the limited number of binding sites with the tracer (labeled, purified analytes). 
The amount of the analyte is inversely related to the detected tracers. Thereby the increase in the 
analyte concentration leads to reduction in the detection signal. The sandwich assay is based on 
two capture agents of which the first is immobilized and the other labeled. The labeled antibody 
is either added at same time or after the sample incubation. In contrast to the competitive assay, 
the proportion of the analyte is directly related to the amount of measured label. The specificity 
is high due to double recognition of the antigen molecule. However, the requirement of two 
different antibodies specific to one antigen set limitations to this assay format.  [25] 
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Figure 19. The variations of ELISA assay: direct, sandwich and competitive assay. The blue ball 
is antigen (Ag denotes antigen) and the green ball is the enzyme. Adapted from ref. [98]. 
 
Immunoassay demands moisture atmosphere and room temperature. In addition, an important 
point related to immunoassays, is the presence of a negative control. Control well does not 
contain the counterpart for the sample analyte, thereby no reaction should occur. Also several 
washes are performed to clean the wells from the unbound reagents. Usually physiological 
solutions, like thiobarbituric acid (TBA) and phosphate buffered saline (PBS), are used. The pH 
of these solutions is adjusted in order to avoid the disruption of the binding interaction. 
Adjustment is needed as the isoelectric point (pI) has an impact on the solubility of the 
molecule. The pI is the pH at which the net charge of a molecule is zero [97, p.730]. The 
blocking agent blocks the free space on the assay well to reduce the background binding caused 
by nonspecific adsorption of reagents and sample. A high level of nonspecific adsorption is seen 
in increase in the negative control signals and decrease in the specificity and sensitivity of the 
assay [5]. A well-known blocking agent is BSA [15]. 
Key features of the immunoassay are a high specificity and a wide detection limit, which range 
to picomolar (pM) or even femtomolar (fM) concentrations depending on the assay type. In 
addition, it usually does not involve the consumption of harmful reagents. However, the time-
consuming and labor-intensive sample handling (incubation steps are measured in hours), long 
analysis times and expensive reagents (over 50-100 µl of each reagent [17]) are often referred to 
possible limitations of conventional immunoassays [1, 5]. Long analysis times originate from 
the inefficient mass transport of immunoreagents from solution phase to surface where the 
actual conjugation takes place [1]. Immunoreaction itself is a fast process.  
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4.3.1 Detection 
The detection in immunoassays is based either on labeled or label-free methods from which the 
labeled methods are more common with biological samples [25]. Labeled methods include 
enzyme tracers and fluorescent dyes, which are detected with various optical and 
electrochemical detection methods. Common enzyme tracers are alkaline phosphatase (AP) and 
horseradish peroxidase (HP) [25]. The enzymes are conjugated to the antigen or to the detection 
antibody in sandwich assay and let to react with a substrate (e.g. 4-nitrophenyl phosphate 
disodium salt hexahydrate, (PNPP)). The reaction is detected by colorimetric means by 
measuring the absorption at a specific wavelength (e.g. 405 nm). Typical fluorescence dyes are 
Alexa Fluor - 647, Cy3 and FITC [5]. These labels are excited upon induction to fluorescence 
light. The drawback of labeled detection is the conjugation of the enzyme or fluorescent label to 
one of the immunoreagents. Modification may cause alterations in the functionality of the 
reagent and it also increases the process complexity [25].  
Label-free methods concentrate on measuring the physical effects caused by biochemical 
binding, like change in the mass loading or thickness of the surface. The detection is done most 
often by acoustic and optical means [25]. These methods do not contain sample modification 
and are efficient, but require expensive machinery and people with skills [25]. They require only 
a single capture receptor but are prone to non-specific binding onto the sensor surface [2]. 
Optical methods include e.g. surface-plasmon resonance (SPR), which is a real-time detection 
method for binding and determination of the binding constants. The binding surface is covered 
with a thin layer, like gold (Au). The method is based on the change of the local index of 
refraction and resonance of surface plasmons in the metal. A light beam is reflected on the 
bottom of a thin metal layer and the angle and wavelength of the reflected light are detected. 
Vikholm-Lundin et al. [8] were able to detect the concentration of 1 ng/ml of CRP antibody Fab 
fragments from purified and 4 ng/ml of serum samples with SPR.  
Another approach to label-free methods is the matrix-assisted laser desorption/ionization 
(MALDI) time-of-light (TOF) mass spectrometry (MS). In MALDI, the substrate containing the 
sample is covered with the light-absorbing matrix molecule (e.g. α-cyano-4-hydroxycinnamic 
acid (HCCA, alpha-matrix [36]). The drying of the matrix creates a crystalline matrix, which is 
vaporized and ionized in the gas phase process by nanosecond-duration laser pulses. The 
released ionized molecules from the sample are accelerated in the electrical field. Depending on 
the mass/charge ratio, the ionized molecules reach the detector at different times. MALDI is 
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liable to detect smaller than 700 Da molecules, but relatively high background and acidity of the 
matrix material are considered as the limitations of the method with antibody analysis [36].  
4.4 Recombinant Fab fragments 
Recombinant Fabs are antibody-binding fragments developed in the laboratory environment by 
means of genetic engineering. Laboratory enables the production of large quantities with ease 
and homogenous quality [99]. Recombinant Fabs constitute of four different domains: VL and 
CL forming an entire light chain and VH and CH1 domains from heavy chain (called as Fd 
fragment, figure 18). One disulfide bond binds the heavy domains together (figure 18). Their 
structure and binding ability is equal to the intact IgG antibodies and the papain cleaved Fab 
fragments (see chapter 4.1) [26]. 
The overall production process of recombinant Fabs include five steps: creation of antibody 
gene library, display of the library on phage surface, affinity selection of antibodies, 
modification of selected antibodies and expression and production of selected antibodies in a 
chosen host system. Recombinant Fab fragments are typically produced with phage-display 
technique in bacteria like the gram-negative Escherichia coli (E. coli) [99]. Besides the bacteria, 
suitable host systems for expression are e.g. yeast (e.g. Pichia pastoris [100]), insect cells (e.g. 
Drosophila S2 cells [101]) and plants (e.g. transgenic potato tubers, Solanum tuberosum cv. 
Désirée [102]), but the low price, well-known production process (due to known genome of E. 
coli) and fast growth (production takes only days rather than weeks) as well as high 
transformation rate favour the bacteria production [99]. The usage of bacteria is also supported 
by the fact no glycosylation is preferred in the Fab fragment production [99]. Obtainable yield 
depends on the chosen production method, but with bacteria expression, yields higher than 1-
100 mg of purified material in litre are common [26]. Figure 20 illustrates the different stages of 
the production of the recombinant Fabs.   
The production process, which is based on genetic engineering, enables to develop antibody 
fragments not present naturally in the mammalian body and also to tailor their properties. For 
instance, tailoring can be made by inserting short amino acid sequences called affinity tags to 
the end of the constant domain [99]. E.g. six histide (His6) has a strong affinity towards divalent 
metal ligands and is therefore important for the purification, immobilization and detection 
prospects [103]. 
 
 
40 
 
 
Figure 20. Schematic presentation of recombinant Fab production by phage display. 
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5 Heterogenic antibody immobilization on polymers 
An essential step in the heterogenous immunoassay is the antibody immobilization, which can 
be performed via physical adsorption, covalent coupling or bio-specific immobilization [24-
25]. Immobilization is defined as [104]:  
"The attachment of molecules to a surface resulting in reduction or loss of mobility." 
The suitable immobilization method is determined by the physicochemical and chemical 
properties of both the surface and the antibody [25]. Therefore there cannot be one generic 
solution for immobilization on polymer support, but the best possible method is chosen case-
specific. The main target is to try to fulfill the requirements for the ideal antibody 
immobilization, which are categorized by Jung et al. [24] to proper and uniform orientation 
(figure 21), minimum antibody modification and soft incubation conditions. With 
microfluidic surfaces, the ideal antibody immobilization often includes some kind of a surface 
modification as this increases the control of interactions between antibody and the supporting 
polymer [1, 5]. Antibodies tend to adsorb onto hydrophobic surfaces. This chapter describes 
the common antibody immobilization methods onto polymer and explains the differences 
between recombinant Fab and intact antibody immobilizations. At the end of the chapter the 
current situation of the antibody immobilization onto SU-8 is reviewed. 
 
 
Figure 21. The functionality of immobilized antibody is based on the orientation of the 
antigen-binding site. The states are referred as (from left to right): end-on Fab up, side on, flat 
on and end-on Fab down.  
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5.1 Physical adsorption  
Physical adsorption or simply non-covalent adsorption is by far the easiest, simplest and most 
cost-effective way to execute antibody immobilization, because there is no need for antibody 
modification or complicated coupling methods [24]. Antibodies are adsorbed to the solid 
support in a simple incubation procedure during which intermolecular forces like electrostatic 
forces, ionic -, hydrogen - and van der Waals bonds or hydrophobic interactions are formed 
[104]. The type of the interaction is based on the local dipoles the interacting molecules have 
between each other [25].  
Antibodies are attached in a random orientation to the surface, which yields random 
placement of the active sites (figures 2 & 21). Some denaturation of the antibodies may occur. 
Also surface loadings can be very high, because the binding capacity is limited only by the 
geometric size of the immobilized antibody (e.g. antibody size is of the order of nm2 in area). 
This causes steric hindrance, which occurs as a reduction in the binding efficiency, because 
antigens are not able to reach the antigen-binding site. Other related problems are relatively 
high background signal, leaching while buffers or other reagents normal to immunoassay are 
used and the need of highly purified samples in order to obtain good responses. [25, 104] 
Studies have shown that the usage of hydrophobic surfaces lead often to antibody 
denaturation [5].  
By reason of all the previous, it is impossible to determine beforehand the fraction of 
antibodies that remain functional after physical adsorption. In the study of Butler et al. [105] 
for example, only 10 % of antibodies were active after immobilization.  
5.2 Covalent coupling 
In covalent coupling antibodies are attached to the surface via highly stable and strong 
covalent bonds [24]. Bond formation requires at least two functional groups, which are 
capable of interacting with each other. There are two types of covalent coupling methods: 
random and site-specific of which the behavior of the former resembles physical adsorption 
and the latter bio-specific immobilization discussed later [104]. Another clear distinction 
between these two is that the random covalent coupling does not require antibody 
modification [104].  
5.2.1 Random covalent immobilization 
Random covalent immobilization occurs between the support and the amino acid residues on 
the surface of the antibody. Most common bond former is lysine, which forms covalent bonds 
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through its amine groups [104]. Working as a nucleophile the primary e-amine group of 
lysine attacks towards the electrophile and forms the bond according to attractive and 
repulsive forces. Formed covalent bonds are more durable towards the processing conditions 
than the bonds in physical adsorption.  
Because no antibody modification is involved in the random covalent immobilization the 
support needs to be chemically modified or contain by nature functional groups capable of 
bond formation. Epoxy -, aldehyde -, carboxyl - and carbodiimide groups -containing 
supports are commercially available and rather used [24-25] (commercially available 
supports, see [106]). In addition different soluble bifunctional linkers, like glutaraldehyde, are 
used while the direct attachment of support and lysine is not possible [104]. Linker molecules 
allow the antibodies to be farther away from the surface, which diminishes the steric 
hindrance.  
Due to the abundance of lysine residues in the antibody structure (a standard intact antibody 
lgG contains at least 70 lysine molecules), the immobilization leads easily to random 
orientation and multipoint attachment [104]. The latter induces uncontrollable orientation and 
steric hindrance.  
5.2.2 Site-specific covalent immobilization   
Compared to random covalent immobilization, site-specific covalent immobilization requires 
antibody modification, but yields more homogenous surface loadings. Modification is 
directed either to carbohydrate moieties found in the Fc region or to thiol groups in the hinge 
region in proteolyted Fab fragments (see figure 20). Carbohydrate residues are treated with 
oxidation reaction. With sulfide bonds the coupling procedure is based on the reduction of 
disulphide bridges by cysteamine or mercaptoethanol treatments. This yields sulfhydryl 
groups. [24, 104] 
Common characteristics to site-specific covalent immobilization are often better biomolecule 
activity, reduced non-specific adsorption, high surface coverage and better control of antibody 
positioning compared to physical adsorption [104]. From practical point of view this 
immobilization method is rather difficult to perform, because it demands antibody 
modification. Modification involves extra processing steps which add the processing time but 
may also affect the antibody structure leading to possible loss of antibody activity.  
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5.3 Bio-specific immobilization  
Bio-specific immobilization reactions are based on the biochemical properties the antibodies 
have. Interactions are less stable than in covalent immobilization. The advantage of this 
method is the oriented and homogenous attachment, which is also reversible in nature and 
enables the repeated use of the same surface. These methods are also gentler due to no need 
of antibody modification. The most common bio-specific based methods comprise antibody-
binding proteins, biotinylation and recombinant proteins with tags. [24-25] 
5.3.1 Antibody-binding proteins 
Antibody-binding proteins, like protein A, are capable of multivalent binding to different IgG 
from different species (humans, mouses etc). Protein A, which is a cell surface protein of 
Staphylococcus aureus, is a single polypeptide chain with molecular weight around 40-65 
kDa [25]. This immobilization method enables the proper orientation of the antigen-binding 
site, because the antibody-binding proteins are affinity coupled to Fc part of the antibody 
whereas the antigen-binding site is left intact [24]. In addition no antibody modification is 
needed. The stability of the bond with antibody-binding proteins is lower compared to the 
covalent coupling [24]. 
Typically protein A is immobilized to the polymer surface either via electrostatic adsorption, 
amine-glutaraldehyde (GA) chemistry or tyrosinase (TR)-catalyzed reaction [20, 22]. Amine-
GA chemistry is based on the covalent linking via amine groups in the protein A. Amine 
groups are present in abundance as there a total of 67-69 amine groups in the protein A 
structure. Therefore, both the adsorption and amine-GA chemistry yield random orientation of 
the protein A on the polymer surface [22]. TR, on the other hand, has a capability to convert 
tyrosine in the protein A into O-quinones, which are highly reactive towards primary amines. 
There are only 5-8 tyrosine residues on protein A and thereby, protein A immobilization 
based on TR-catalyzed reaction is said to be more site-selective [22]. TR-catalyzation results 
in better antibody activity compared to amine-GA chemistry immobilization. In the study of 
Yuan et al. [22], TR gave sevenfold and GA fourfold increase in antibody activity when 
compared to the PMMA surface where physical adsorption of the antibody was done. In all of 
the cases, the surface was first functionalized with plasma oxidation prior immobilization 
steps (300W, 30s, 20 sccm) (figure 22).  
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Figure 22. Schematic presentation of tyrosinase-catalyzed protein A based immobilization of 
antibodies. Before immobilization otherwise inert PMMA surface is treated with oxygen 
plasma and poly(ethyleneimine). Adapted from ref. [22].  
 
5.3.2 Biotinylation 
In biotinylation, the antibody is labeled with biotin, a vitamin H, which can act as an affinity 
tag. Biotin can form near irreversible bond with avidin, which is a glycosylated protein 
capable of binding up to four molecules of biotin. Similarly to avidin, streptavidin is capable 
to bind biotin. The biotin-avidin bond is one of the strongest known non-covalent bonds as 
the Kd value for it is as low as 10-15 [24, 104]. The avidin-biotin bonding enables harsh 
incubation conditions as the bond is unaffected by the pH, temperature, organic solvents, 
enzymatic proteolysis and other denaturing agents [22, 104].  
Biotin is coupled to the antibody through e.g. carboxylic acid groups [24]. The carboxyl 
groups react with the lysine molecules on the antibody molecule. A more controlled coupling 
is done e.g. through disulphide groups [24]. In addition to labeling the antibody with biotin, 
this method also requires the avidin immobilization onto the substrate [104]. An example of 
this is the surface grafting by poly(ethylene glycol) (PEG), to which the avidin is coupled by 
covalent coupling [104]. The chemical and recombinant methods have been used to enhance 
the properties of avidin and streptavidin. This offers e.g. improved stability and more 
controlled biotin binding [25]. NeutrAvidin and NitrAvidin are examples of improved 
molecules.       
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5.3.3 Recombinant proteins with tags 
Recombinant proteins are antibodies, which have been modified genetically. The fabrication 
method enables the attachment of a tag which was originally added for the purification 
purposes [27]. However, the tag also serves as an immobilization site as e.g. Hale et al. [34] 
have shown. During the cloning, the tag is attached to the C-terminal side of the antibody. 
Therefore, the tag is always on the opposite site of the antigen-binding site yielding optimal 
orientation of the antibody. The advantages of the recombinant proteins with affinity tags are 
the compatibility with organic solutions, low immunogenicity, reusability, efficient 
orientation capability and efficacy under native and denaturing conditions [104]. 
An example of the tag is a short amino acid chain, like histidine (His) – tag, which is made up 
of usually six consecutive histidine amino acids (figure 23). The antigen-binding ability of 
Fab fragment is not interfered with His-tag attachment even though multiple tags are attached 
[107]. The efficiency of His-tag is based on the affinity it has towards divalent transition 
metals (e.g. nickel (Ni2+), zinc (Zn2+) and cobalt (Co2+)) in aqueous solutions (figure 23) 
[103]. The imidazole rings on His-tag molecule have the chelating ability of IDA coordinated 
cobalt ions (figure 24). The formed coordination bonds are irreversible [103]. In addition to 
His-tags, cysteine (Cys) –tags are common [24].   
 
 
Figure 23. Histidine6-tag is affinity bonded to IDA-Co chelation system. His6-tag is marked 
with red box. Adapted from ref. [103].  
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Figure 24 summarizes the physical adsorption, covalent coupling and bio-specific 
immobilization and the parts of the antibody which enables the antibody immobilization. A 
good review about the antibody and protein immobilization in general is in [25, 104]. Table 5 
presents the comparison between advantages and disadvantages of different immobilization 
methods. 
 
Figure 24. The antibody structures which enable different immobilization methods. 
Table 5. Comparison of different immobilization methods (Ab denotes antibody). From refs. 
[24, 108].  
IMMOBILIZATION 
METHOD ADVANTAGES DISADVANTAGES 
Adsorption 
Minimal manipulation, No Ab 
modification, Mostly high 
immobilization level 
Random orientation, Ab  denaturation, 
Nonspecific protein binding, Leakage 
of antibody from surface 
Covalent coupling 
Stable immobilization, 
Commercially available 
surfaces 
Random orientation, Ab modification, 
Possible denaturation 
Bio-
specific 
immobiliz
ation 
Antibody-
binding 
proteins 
Oriented immobilization, No 
Ab modification, Mild 
incubation 
Surface stability, Not suitable for 
sandwich assays, Additional processing 
step for antibody-binding protein 
immobilization 
Biotinylation Oriented immobilization, Mild incubation  
Ab modification, Additional processing 
step for avidin immobilization  
Affinity tags 
Oriented immobilization, Mild 
incubation, genetic Ab 
engineering 
Surface stability 
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5.4 Fab immobilization and the differences to the immobilization of intact antibodies 
The difference between intact antibody and truncated fragment immobilization is the size and 
the advantages it brings [27, 108]. The Fab fragments are much smaller (only one third of the 
whole antibody structure), which enables denser packing of molecules and thereby higher 
surface loadings on the substrate surface. This improves further the assay sensitivity. The 
smaller size of the fragment also provides faster assay kinetics. In the study of Brockmann et 
al. [27] the Fabs offered 3-folds higher binding capacity, faster kinetics and better detection 
limit of thyroid-stimulating hormone (TSH) compared to the whole monoclonal antibodies 
(0,09 mIU/L TSH and 0,26 mIU/L TSH, respectively). The Fab was 49 kDa in size whereas 
the monoclonal antibody 155 kDa, respectively.  
5.5 Immobilization onto SU-8 substrate  
There are only a few studies concerning the antibody immobilization onto SU-8 surface from 
which none presented immobilization of antibody fragments or recombinant antibodies. Two 
studies, where antigens were immobilized instead of antibodies were found [35, 109].  Table 
6 summarizes the current situation of the antibody immobilization onto SU-8. 
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Table 6. Antibody immobilization onto SU-8.  
ANTIBODY ANTIGEN SURFACE MOD. 
IMMOB. 
METHOD 
BLOC
KING OTHER REF. 
Human lgG 
 
FITC-tagged 
goat anti-
human IgG 
- Physical adsorption 
BSA 
Only weak 
and random 
fluorescence 
detected. [32] 
Aminosilanization 
(H2SO4+ AEAPS 
+ glutaraldehyde) 
Covalent 
immobilization  
Mouse IgG 
Cy3-
conjugated 
antimouse-
IgG 
Aminosilanization 
(H2SO4 + APTES 
+ glutaraldehyde) 
Biospecific 
binding  
(protein A) 
BSA 
Antigen 
concentration 
of 1,5 ug/ml  
detected. 
[110] 
Alexa Fluor 
647-labeled 
chicken anti-
mouse IgG 
 
- - Covalent immobilization - 
Not an 
immobilizatio
n study 
[77] 
Human IgG 
 
FITC-tagged 
goat anti-
HIgG 
 
Carbodiimide 
chemistry 
(NaOH/HCl 
treatment + 
glycine) 
Covalent 
immobilization 
PBSTB 
Glycine was 
the most 
effective, 
physical 
adsorption the 
worst. 
[33] 
Succinimide 
chemistry 
(NaOH/HCl  + 
11-MUA) 
Covalent 
immobilization 
- Physical adsorption  
Anti-CRP-
cAb 
and anti-
CRP-Cy5-
dAb1 
- 
Aminosilanization 
(CAN + APTES + 
glutaraldehyde) 
Covalent 
immobilization 
BSA 
Sandwich 
assay: 
LOD2 of 300 
ng/ml CRP 
[31] 
CAN Covalent immobilization 
LOD2 of 80 
ng/ml CRP 
- Physical adsorption 
LOD2 of 30 
ng/ml CRP 
Human lgG 
 
FITC-tagged 
goat anti-
human IgG 
- Physical adsorption BSA 
Only weak 
and random 
fluorescence 
detected [28] 
HWCVD + 
glutaraldehyde 
Covalent 
immobilization  
1 dAb = detector antibody, cAb = capture antibody 
2 LOD = limit of detection 
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6 Materials and methods 
6.1 Fabrication of the SU-8 substrates 
The SU-8 layers were spin-coated on top of a RCA-1 and RCA-2 cleaned, single-side 
polished silicon wafers with a crystal orientation of <100>. The wafers were baked in a 120°C 
oven from 1 to 24 h prior the SU-8 layer fabrication. The fabrication process of all the SU-8 
surfaces applied in the experimental part followed the five-step photolithographic process for 
negative photoresists presented in chapter 3.2: spin-coating (WPB Resist Coating, STANGL), 
soft bake, UV-exposure (MA6/BA6, Süss MicroTec) and post-exposure bake and 
development. The hotplate in the bakes was either programmable (UniTemp GmbH) or 
adjustable, leveled hotplate (Präzitherm). 
6.1.1 Planar SU-8 surface 
Planar SU-8 surfaces of 14.5 µm in thickness were fabricated using spin speed of 9000 rpm 
for 45 s. The layer was first soft baked at 65°C for 5 min and finalized at 95°C for 8 min. UV-
exposure of 5 s was applied. The exposure step was done without the mask (flood-exposure) 
and no development step was needed, because the whole layer had been in contact with the 
UV-light. The layer was finalized with the 8 min PEB at 95°C. The wafer was cut into 1.5 cm 
x 1.5 cm pieces with a diamond pen.  
6.1.2 Nanostructured SU-8 surface 
SU-8 surface was structured with nanopillar features by using a composite stamp of PDMS / 
hard-PDMS (h-PDMS). The mask for the composite stamp was made of black silicon. The 
black silicon master was fabricated in a maskless Deep Reactive Ion Etching (DRIE) process. 
The features from the master were replicated to the composite PDMS stamp in an UV-
embossing process. The black silicon mask fabrication and UV-embossing process are 
reported elsewhere, in [46] and [111], respectively.  
The nanostructured SU-8 surface was 14.5 µm in thickness. Same spin-coating and bake 
parameters were used as with the planar surface (see chapter 6.1.1). The composite stamp was 
placed on top of a SU-8 layer during the soft bake, when the temperature was dropped from 
95°C to 80°C. The stamp was gently pressed with tweezers to get rid of the air bubbles. The 
total time for the stamping process was 10 min. Upon UV-exposure, increased exposure time 
(60 s) was applied compared to the planar surface fabrication (5 s). The increase in exposure 
time both improved the adhesion of SU-8 to underlying silicon and ensured sufficient 
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crosslinking initiation to SU-8 (some of the UV-light is absorbed to the composite PDMS 
stamp). The stamp was removed after PEB, when the temperature reached the room 
temperature (RT). No development step was needed. The scanning electron microscope 
(SEM) image of the nanostructured surface is shown in figure 25. As was with planar surface, 
the wafer was cut into 1.5 cm x 1.5 cm pieces after finishing the fabrication process. 
 
Figure 25. SEM-image of nanostructured SU-8 surface, which resembles grass or forest. 
 
6.1.3 Immunochip design 
Immunochip structure was designed on the basis of our previous research (see chapter 2.4) 
[37]. Triangle patterned microfluidic channels were found to be able to direct the water flow 
to a certain direction with a certain layer thickness and contact angle. The phenomenon is 
discovered when triangles are placed tips towards the proceeding meniscus. The chip 
contained two layers with equal depths. The base layer was planar and the second layer 
contained the channel design. Three different layer thicknesses were used: 14.5; 17.8 and 21.2 
µm. Fabrication parameters for different layer thicknesses are presented in the table 7. At the 
end of the process, SU-8 structures were developed with PGMEA, which was followed by 2-
propanol (IPA) rinsing and nitrogen dry.  
The design of the chip is shown in figure 26. Fabricated channel chip was 1.5 cm in width and 
3 cm in length. In addition to channel, the design consisted four square-shaped inlets from 
which three where positioned on the side and one at the beginning of the channel. The former 
were 0.5 cm x 0.5 cm and the latter was 0.7 cm x 0.7 cm in size. The inlets on the side were 
connected to channel by 1 cm long connection channel, also structured with squares. 
Triangles inside the channel were 80 µm x 20 µm in size. They were placed in rows with 10 
µm distance to the adjacent triangle as a total number of 150 triangles in a row. Three 
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different distances between consecutive rows where used: 17, 20 and 23 µm. Depending on 
the distance, there was a slight variation in the number of consecutive rows. All the inlets 
were structured with a square pattern. One square was 10 µm x 10 µm in size and the distance 
to every direction was 10 µm. In the places where inlets connected to channel, the square 
patterning was continued between triangle structures in order to facilitate the progression of 
the liquid.   
 
Figure 26. Fabricated immunochip structure made of SU-8. Detailed optical microscope 
pictures are presented: the triangle and square structures (magnification of 50) and the 
structure where the inlet connects to the channel structure (magnification of 20). 
 
Table 7. Immunochip fabrication parameters and the channel details (exp. denotes exposure 
and dev. is development). 
THICKNESS SPIN SPEED AND TIME SB EXP. PEB DEV. 
14.5 μm 9000 rpm, 45 s 
in 65°C 5 min, 
in 95°C 8 min 
 
5 s in 95° 8 min ~ 5 min 
17.8 μm  9000 rpm, 36 s 
in 65°C 5 min, 
in 95°C 8 min 
 
5 s in 95° 8 min ~ 5 min 
21.2 μm 9000 rpm, 30 s 
in 65°C 5 min, 
in 95°C 8 min 
 
5 s in 95° 8 min ~ 5 min 
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6.2 Surface characterization  
The SU-8 surface was characterized with Attenuated Total Reflection Fourier Transform 
Infrared (ATIR-FTIR) Spectroscopy measurement to ensure there are free epoxy groups, 
which are able to take part in the immobilization process.  
Five different samples (denoted as sample1 to sample5) were fabricated. Sample1 was similar 
to planar SU-8 surface fabricated according to chapter 6.1.1. The samples 2 and 3 were 
fabricated otherwise as planar SU-8 surface but the exposure time was either diminished to 
2.5 s (sample2) or increased to 20 s (sample3) from normal 5 s (sample1). The other two 
remaining samples (samples 4 and 5) were fabricated with either diminished PEB time of 4 
min (sample4) or increased PEB time of 20 min (sample5). The longer exposure time is 
supposed to diminish the number of free epoxy groups, because of more effective cross-
linking process [30]. With different PEB samples, no changes in the amount of free epoxy 
groups should take place as the change in PEB time within all of the samples is somewhat 
moderate. The amount of free epoxy groups per SU-8 monomer can be estimated by 
calculating the ratio of peak heights of wavelengths ~ 914 cm-1 and ~ 1608 cm-1 [30]. The 
former is the vibration of epoxy ring and the latter indicates the stretching of the benzene.  
The measurements were done with Unicam MATTSON 3000 FTIR spectrometer and PIKE 
Technologies GladiATR® equipment with a diamond crystal, at Laboratory of Polymer 
Technology, in Otaniemi. The analysis program was EZ OMNIC. The samples were placed 
upside down, SU-8 coated side towards the diamond crystal. 
6.3 Antibody-antigen model system 
For the immobilization studies the anti-mycophenolic acid (α-MPA) antibody F5 in PBS 
buffer and its antigen mycophenolic acid (MPA) as an alkaline phosphatase (AP) conjugate 
were chosen. Antibody has a His6-tag at the opposite site to the antigen binding site, which 
enables the oriented immobilization. Antigen is composed of four MPA molecules conjugated 
to one AP enzyme. The conjugation degree has been checked with mass spectrometer. 
Negative controls were unconjugated AP enzymes. Both the antigen and antibody were 
provided by collaborates at VTT.  
In the previous experiments this antigen-antibody pair has been shown to be suitable model 
system for various applications. Antibody has reasonable affinity for immobilization studies 
(100-200 nM) and the conjugation of the antigen to the detection enzyme (AP) directly makes 
possible the one step assay development and the signal is efficiently amplified. 
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6.4 System set-up for immobilization studies 
Before starting the actual comparison tests with random and oriented immobilization studies, 
three different approaches for the immobilization step were designed: PDMS stamp, 
immersion of the SU-8 sample to the protein solution and droplet-based immobilization 
(figure 27). In PDMS stamp approach, the SU-8 surface was covered with 7 mm thick PDMS 
stamp with a hole in the middle (figure 29). PDMS (Sylgard® 184, Dow Corning) stamp was 
fabricated by mixing resin material and curing agent in a ratio of 10:1 in a Petri dish. A short 
vacuum treatment removed the air bubbles, which were formed during the mixing procedure. 
The stamp was finalized with 55°C oven treatment for overnight (o/n). The hole, 7 mm in 
diameter, was made by hulpiber. The purpose of the hole was to define the area under 
immobilization. PDMS stamp was removed before the detection step.   
 
Figure 27. Different immobilization approaches utilized in the preliminary tests for SU-8: 
PDMS stamp, SU-8 piece immersion to protein solution and droplet-based immobilization.  
 
The second approach comprised the immersion of the whole SU-8 piece to the protein 
solution. The whole area was therefore in contact with the protein solution. SU-8 pieces were 
turned upside down and sunk to the solution. As a highly hydrophobic surface the SU-8 
pieces will float on the liquid without turning upside down. The few formed bubbles were 
removed by gently knocking the pieces with tweezers. In droplet-based approach, the protein 
solution was incubated onto SU-8 surface. The hydrophobic surface of SU-8 enables precise 
droplet formation.  
55 
 
6.5 α-MPA Fab F5 immobilization onto SU-8 surface 
The immobilization studies both in random and oriented way were performed with 1.5 cm x 
1.5 cm SU-8 pieces (area 2,3 cm2), which were incubated in a lidded 6-well plate template 
having a wet paper in the lid. Assay conditions were adapted from routine immunoassay in 
microtiter plate for polystyrene. Between all the steps, the SU-8 pieces were rinsed three 
times in 2 ml of double-distilled water (DDIW). Rinsing was performed without incubation 
time.  
6.5.1 Random immobilization 
Random and covalent immobilization occurs between the lysine residue on the surface of the 
recombinant antibody fragment and the free epoxy group on SU-8 surface. The abundance of 
lysine residues leads to the random placement of the antigen-binding sites, which are either 
active, partly active or inactive as presented in figure 28.  
40 µg of α-MPA Fab F5 in phosphate buffered saline (PBS) was manually spotted at a 
volume of 100 µl per drop onto pieces of SU-8. Droplet was placed in the middle of SU-8 
piece and incubated o/n at room temperature (RT) in moisturized chamber. Free epoxy groups 
were blocked with blocking reagent, 1% bovine serum albumin (BSA, Sigma-Aldrich Co, 
USA) in 0,1 M sodium carbonate buffer (pH 9.6). SU-8 pieces were embedded in 2 ml of 
BSA blocking solution and incubated for two hours in RT with continuous shaking 
movement. 1.3 µg of MPA-AP in Tris-buffered saline (TBS) was spotted at a volume of 50 µl 
in the middle of the each SU-8 piece and incubated for one hour in RT. The principle of 
random immobilization is presented in figure 28.  
 
Figure 28. The principle of random immobilization in this thesis. The His6-tagged antibody 
fragments are immobilized via lysine residues onto the free epoxy groups at the SU-8 surface.  
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4-Nitrophenyl phosphate disodium salt hexahydrate (PNPP, Sigma-Aldrich, USA) substrate 
in Diethanolamine MgMl2 – buffer (Reagena-buffer, Reagena, Finland) in a concentration of 
2 mg/ml was applied for the detection. A droplet of 150 µl of aforementioned solution was 
placed in the middle of the SU-8 piece and was left to incubate for 51 min. A 100 µl of the 
incubated solution was transferred to the microtiter plate to measure the color change with 
absorbance using wavelength of 405 cm-1 (analysis program: Varioskan).  
6.5.2 Oriented immobilization  
In the oriented immobilization, the antibody is coupled to SU-8 surface through a chelation. 
Iminodiacetic acid (IDA) – cobalt (Co) system anchors the His6-tagged recombinant antibody 
fragments onto SU-8 surface by forming a bond between the Co-atom and histidines in the 
His6-tag. The system is chelated and made extremely stabile by increasing the oxidation state 
of cobalt from +II to +III in an oxidation step. This irreversible complex orients all the 
antigen-binding sites towards the liquid phase. Immobilization principle was based on the 
study of Hale et al. [34].  
Oriented immobilization process started by fabrication of 1 M IDA solution. First, 100 nM 
sodium borate (Na2B4O7) solution was made by mixing 3.8 g of Na2B4O7 (Sigma-Aldrich, 
USA) to 100 ml of MilliQ-water (QPak, Millipore). Solution was stirred with magnetic stirrer 
in RT until all the sodium borate was dissolved. Next, 5.4 g of IDA (Sigma-Aldrich, USA) 
was stirred with 40 ml of 100 nM sodium borate solution. Before heating few milliliters of 5 
M sodium hydroxide (NaOH) was pipetted to the solution. The temperature was adjusted to 
50°C and stirring was continued until the solution cleared. The pH was measured (Knick pH-
Meter 761 Calimatic) and adjusted to required 8.50 with 5 M NaOH.  
Each SU-8 piece was embedded in 2 ml of IDA solution. The pieces were placed SU-8 
surface downwards to avoid the floating caused by the hydrophobic SU-8 coating on top of 
the silicon. Possible air bubbles between the base of 6-well plate template and SU-8 surface 
were eliminated by gently knocking the SU-8 piece with tweezers. The pieces were incubated 
in 1 M IDA o/n with continuous shaking movement in RT.  
Next the SU-8 surfaces were treated with cobalt. First, MilliQ-H2O was filtered in a side-
armed Erlenmeyer flask with a HVLP 0.45 µm membrane. The process was done in the 
vacuum by adjusting the compressed air flow on. After filtering the bottled water was treated 
with helium gas (He). The He-treatment of 250 ml of filtered water took 5 min. The water 
was treated with helium in order to maintain the oxidation state of cobalt during the antibody 
fragment immobilization. Next, cobalt(II)-chlorid-hexahydrat (CoCl2· 6 H2O, Merck Oy, 
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Finland) was dissolved in degassed DDIW in a concentration of 100 mg/ml. Because CoCl2 is 
poisonous, it was weighted in a hooded scale and dissolved to MilliQ-H2O immediately after 
scaling. The piece was embedded and incubated in a 2 ml of cobalt solution in continuous 
shaking movement for one hour in RT. 40 µg of α-MPA Fab F5 in PBS was manually spotted 
at a volume of 100 µl per drop onto pieces of SU-8 and incubated o/n in RT.   
After antibody immobilization cobalt was oxidized from oxidation state of +II to +III. 30 % 
hydrogen peroxide (H2O2, Sigma Aldrich, Finland) was diluted in DDIW in a ratio of 1:1000. 
A droplet of 150 µl of aforementioned solution was placed in the middle of the SU-8 piece 
and left to incubate for 1.5 h in RT. SU-8 pieces were embedded in 2 ml of BSA blocking 
solution and incubated for two hours in RT with continuous shaking movement. 1.3 µg of 
MPA-AP in TBS was spotted at a volume of 50 µl in the middle of each SU-8 piece and 
incubated for one hour in RT. Detection step was done as in random immobilization. The 
principle of oriented immobilization is illustrated in figure 29.  
 
Figure 29. The principle of oriented immobilization in this thesis. The His6-tagged antibody 
fragments are immobilized via IDA-Co -system onto the free epoxy groups at the SU-8 
surface. 
6.6 Immobilization parameter studies 
Immobilization procedures were optimized by means of antibody incubation time, antigen 
concentration, different incubation buffers in the antibody immobilization, pH (only for 
random immobilization), surface modification (both surface patterning and plasma oxidation 
treatment) and storing stability of the immobilized antibody as well as the substrate. All the 
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studies were performed with two or three parallel samples and the results were reported as a 
mean value of these separate results. Statistical analysis was performed to study the 
significance of the results. Significance was evaluated by Student’s t-test, and the level of 
significance was set as P < 0.05.   
6.6.1 Incubation time  
The effect of the incubation time to the immobilization efficiency was studied in five different 
time points: 10 min, 30 min, 2 h, 4 h and o/n. Control sample was chosen to be o/n incubation 
as it is known to be sufficient time for the immobilization reaction if the immobilization is 
possible in general.  
6.6.2 Amount of antigen 
The sensitivity of SU-8 immobilization system was tested by diluting the antigen solution by 
1x TBS. The starting point for the dilution series was 1:1 dilution (c = 0.025 mg/ml), which 
contained 1.27 µg of antigen on the SU-8 surface. The used dilutions were 1:1, 1:2, 1:5, 1:10, 
1:20 and 1:100. Control sample was the dilution of 1:1.  
6.6.3 Serum vs buffer 
To demonstrate the feasibility of SU-8 surface for the analysis of pure biological samples, the 
antibody immobilizations were carried out with the human serum in addition to 1x PBS 
solution. Random and oriented immobilizations were done as mentioned in the chapter 6.5, 
but in addition to mixing the antibody to 100 µl in PBS, mixing with 100 µl in human serum 
was applied. Also the effect of incubation time was studied using o/n and 10 min time points. 
Control sample was buffer based immobilization with o/n incubation time.  
6.6.4 pH in immobilization 
The effect of pH was studied by using PBS solutions, which differed in pH, in random 
immobilization. The antibody immobilization pH in random immobilization is near pH 7 (pH 
of 1x PBS solution) whereas the pH in oriented immobilization is near pH 8.50 (IDA-Co 
chelation changes the surface pH). The adjustment of the pH was done with 5M NaOH 
solution. First a 300 ml of 1x PBS solution was prepared with measured pH of 7.24. By 
removing 100 ml of PBS solution of pH 7.24 and adding 3 droplets of 5M NaOH with a 
Pasteur – pipette the pH value was adjusted to 8.05. Again 100 ml of PBS solution was 
removed and additional 1 droplet of 5M NaOH added. The solution pH was 9.93. Antibody 
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was mixed to 100 µl in each of the prepared PBS solutions. Control sample was PBS solution 
with pH 7.24.  
6.6.5 Surface modification of SU-8  
The effect of surface wetting was studied by treating the SU-8 surface with oxygen plasma by 
Reactive Ion Etching (RIE) before taking the pieces out of the cleanroom environment. 
Oxygen plasma renders SU-8 surface more hydrophilic [80]. Etching conditions were chosen 
according to our earlier research (power 100, pressure 150) [37]. The SU-8 surface was RIE-
treated for 5 s and 60 s. The contact angle was measured immediately after the RIE-treatment. 
Control sample was SU-8 surface, which was not treated with RIE.  
The effect of surface structuring on immobilization efficiency was studied by applying 
nanostructured SU-8 surfaces which were fabricated according to chapter 6.1.2 as the 
immobilization support. Control sample was planar surface. Also the combined effect of RIE-
treatment and nanostructuring on immobilization efficiency was studied. The RIE-treatment 
parameters were otherwise the same as mentioned above, but only the treatment time of 5 s 
was used. Control sample was planar SU-8 surface, which was not treated with RIE. 
6.6.6 Storage stability of immobilized antibody  
The storage stability of immobilized antibody in both wet and dry conditions was studied. The 
immobilization procedures were done according to the instructions in chapter 6.5 until the 
antigen incubation step.  The wet storing was done by embedding the SU-8 samples in 2 ml of 
TBS and by keeping the wet paper in the lid of the 6-well plate template. The plate was sealed 
with paraffin in order to keep the well moisturized environment in the plate. The dry stored 
samples were in a lidded 6-well plate without TBS solution and wet paper. The 
immobilization procedures were continued normally after one day or one week storing time 
depending on the test. 
6.6.7 Storage stability of SU-8  
In substrate storage stability studies, the SU-8 coated wafers were fabricated as normal, but 
after finishing the process, they were stored in cleanroom conditions for 1, 2, 3 or 4 weeks. 
Control wafers were fabricated on the day the studies were started.   
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6.6.8 Simultaneous comparison of random and oriented immobilizations  
The immobilization efficiency between random and oriented immobilizations was evaluated 
by comparing the immobilization results from previously described parameter studies 
(chapters 6.6.1 - 6.6.3 and 6.6.5 - 6.6.7). Only results from the studies, which were identical 
in terms of reagents (prepared at the same time) and SU-8 substrates (from the same wafer) 
for both immobilizations, were included in the analysis. Table 8 presents the included studies. 
 
Table 8. Immobilization studies, which were included in the immobilization efficiency 
comparison studies between random and oriented immobilizations.    
PARAMETER CHANGES 
Incubation time 10 min, 2h, o/n 
Amount of antigen Dilutions 1:1, 1:2, 1:5, 1:10, 1:20, 1:100 
Serum vs buffer 
Serum vs PBS;  
Serum vs PBS with incubation times of 10 min and o/n  
Surface modification 
Oxygen plasma treatment for 5 s or 60 s;  
Nanostucturing and oxygen plasma treatment for 5 s 
Antibody stability over time Wet and dry storing for 1 week  
SU-8 stability over time Storing at cleanroom for 1, 2, 3 and 4 weeks 
 
The immobilizations were also compared by the remaining antibody - antigen stability after 
successful antibody immobilization study. After the substrate reaction, the SU-8 samples were 
again embedded in 2 ml of TBS for o/n in RT. A wet paper was kept in the lid of the 6-well 
plate template. Next day the SU-8 samples were transferred to a new well and a new substrate 
was placed on top of a SU-8 piece and the absorbance of the remaining antibody –antigen 
complex measured. The absorbance measurement was repeated. The substrate incubation in 
addition to absorbance was again repeated after a new antigen immobilization was made, but 
this time incubated with the BSA blocking solution.  
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6.7 SU-8 as a MALDI- base 
The possibility to use SU-8 as a matrix-assisted laser desorption/ionization (MALDI) –base in 
mass spectrometer (MS) measurements was studied by using both planar and nanostructured 
SU-8 surfaces with and without RIE-treatment (time: 5 s, power: 100, pressure: 150; 
parameters from our previous study [37]) for which the antibody immobilization was done 
according to chapter 6.5. The correct functioning of immobilization was proven by extra 
sample for which the immobilization procedure was followed through (including also the 
substrate incubation, detection by eye). All the measurements were done at Biomedicum, in 
Helsinki.   
The SU-8 samples were taped to metallic MALDI plate with conductive tape, after which the 
MALDI-matrix solution was pipetted in a volume of 1 μl on top of the samples. The solution 
consisted of a saturated solution of 3,5-dimethoxy-4-hydroxycinnamic acid also known as 
sinapinic acid which is commonly used with peptides, proteins and glycoproteins. The solvent 
was 40 % acetonitrile (ACN) and 0.1 % trifluoroasetic acid (TFA). Before loading the 
MALDI-base in the mass spectrometer equipment, the droplets were allowed to dry in a 
normal RT for about 10 min. Samples were shot 3000 times in a series of 250 shots. The 
results were therefore represented as sum spectra of 3000 shots. For comparison the standard 
spectra of pure samples of α-MPA F5 Fab and MPA-AP were also measured.    
6.8 Immunochip – studies 
The purpose of the immobilization parameter studies made with planar surfaces was to find 
out an optimal immobilization procedure for the immunochip design. In addition to 
immobilization parameters, the proper functioning of the chip structure requires the proper 
conditions in terms of contact angle, layer thickness and the distance between consecutive 
triangle rows.   
6.8.1 Contact angle measurements 
The contact angle between immunochip surface and α-MPA Fab F5 in PBS was measured by 
goniometer (KSV Cam 100). The antibody solution was placed onto SU-8 surface with 
volume of 1 µl and the contact angle was measured optically. Every contact angle was 
measured from three different spots and the results were reported as a mean value of these 
separate spots. In addition to standard contact angle measurements, measurements where done 
with decimal dilution series of PBST solution (0,05% Tween in PBS, Tween20®) and 
aforementioned solution mixed with α-MPA Fab F5 (20 µl in 100 µl PBST). Also the effect 
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of using different dilutions of PBST-solution in random immobilization as a buffer solution 
was studied. The immobilization was done as mentioned in chapter 6.5.1. Control sample was 
random immobilization with 1x PBS solution.   
6.8.2 Directed capillary flow studies 
The correct flow of the antibody solution in the immunochip structure was studied by flow 
tests. Immunochips were fabricated according to chapter 6.1.3 with all the mentioned 
thicknesses and triangle row distances. The surface contact angles (30° and 40°) and the RIE-
treatment conditions (time: 5 s, power: 100, pressure: 150), which enabled the correct flow 
profile, were chosen according to our earlier research [37]. The adjustment of the contact 
angles was done by double RIE-treatment from which the first treatment was done 
immediately after finishing the SU-8 processing and the second after one or two days of 
cleanroom storing.  
Flow studies were executed by manually pipetting a droplet of 1 µl in volume of α-MPA Fab 
F5 solution (2.1 mg/ml) or water to the middle inlet. Solution was allowed to flow freely from 
the inlet. Experiments were done in RT. Figure 30 presents the starting point of the flow 
studies.  
 
Figure 30. Directed capillary flow study on immunochip. The desired flow pattern is marked 
with red arrows.   
6.8.3 Antibody immobilization on immunochip 
The immobilization of α-MPA Fab F5 in PBS onto immunochip was studied with random 
immobilization. Compared to the immobilization principle presented in the chapter 6.5, the 
amounts of used reagents were scaled to correspond to the size of the chip structure. Because 
detection was done with fluorescence microscope (the substrate reaction is not sensitive 
enough), a fluorescence labeled MPA-AP antigen was used. Based on earlier studies [30], 
Alexa 647 –label was chosen. The used immobilization parameters are presented in the table 
9. 
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Table 9. The random immobilization parameters in immunochip studies. 
IMMOBILIZATION STEPS INCUBATION TIME AMOUNT 
α-MPA Fab F5 in PBS o/n 5 µl 
Blocking with 1% BSA 1 h 3 ml 
Alexa 647 -labeled MPA-AP 1 h 1 µl 
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7 Results and discussion 
7.1 ATIR-FTIR -measurements of SU-8 
ATIR-FTIR -measurement was applied to prove the existence of free epoxy groups as both 
random and oriented immobilizations developed here occur via the free epoxy groups on SU-8 
surface. The spectrum of SU-8 surface, which was fabricated with the standard parameters 
(sample1), is presented in figure 31 (relevant peaks marked with functional groups). The spectra 
of the other samples (sample2 to sample5) and explanations of the relevant peaks in the spectra 
are presented in appendix A. The calculated values of the different samples (sample1 to 
sample5) are collected to table 10.  
 
Figure 31. ATIR-FTIR spectrum of standard SU-8 surface (sample1: 5 s exposure and 8 min 
PEB). The peak close to 914 cm-1 denotes epoxy group and the peak around 1608 cm-1 benzene 
ring, respectively.  
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Table 10. Number of free epoxy groups per SU-8 monomer.  
SAMPLE 
(exposure + PEB time) 
PEAK 
HEIGHT AT 
914 cm-1 
PEAK 
HEIGHT AT 
1608 cm-1 
RATIO 
(I) 
NUMBER OF 
FREE EPOXY 
GROUPS PER SU-8 
MONOMER 
SAMPLE1 (5s + 8 min) 8 11 0,73 1,5 
SAMPLE2 (2.5s + 8min) 8 4 2,0 4 
SAMPLE3 (20s + 8min) 4,5 6 0,75 1,5 
SAMPLE4 (5s + 4min) 8 10 0,8 1,6 
SAMPLE5 (5s + 20min) 6 6 1,0 2 
 
ATIR-FTIR -results with the different exposure times (sample1: 5 s; sample2: 2.5 s; sample3: 
20 s) were in accordance with the previous study [30]. The results indicate the shorter exposure 
time leaves greater amount of free epoxy groups onto SU-8 surface. Also the results obtained 
with the different PEB times (sample1: 8 min, sample4: 4 min, sample5: 20 min) were logical. 
The somewhat higher PEB time as was with sample5 is not long enough to eliminate the epoxy 
groups from the SU-8 surface. According to the previous study [30], the PEB time should have 
been around 2 h and the baking temperature close to 150ºC in order to PEB to eliminate the 
epoxy groups from the SU-8. As can be seen from the spectra (figure 31 and appendix A), all of 
our samples still have the peak for epoxy group, indicating all of them could serve as a reactive 
site for the covalent attachment of different molecules, e.g. antibodies.  
7.2 System-setup study results 
Three different approaches for immobilization step were evaluated before starting the actual 
study: PDMS stamp, immersion of the SU-8 sample to the protein solution and the droplet-
based immobilization. The PDMS stamp was rejected due to weak adhesion between PDMS 
and SU-8. The weak adhesion allows the reagents to leak outside the defined area. This could 
lead to ineffective blocking or antibody / antigen immobilization, which would have been 
shown as a false positive result. PDMS is also known to have tendency to absorb proteins [78]. 
The amount of absorbed protein to stamp material is difficult to determine.  
Also the immersion approach was rejected as it consumed high amounts of expensive reagents. 
The effective immersion demands at least 2 ml of reagent, which is 20 times higher 
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consumption compared to the droplet-based approach, where only 100 µl is needed. In addition, 
the immersion requires equal sized SU-8 pieces to have comparable immobilization area 
between parallel samples. Referring to the reasons explained above, the droplet-based approach 
was chosen for this preliminary immobilization study.  
7.3 Immobilization tests 
7.3.1 Incubation time 
As can be concluded by the nature of oriented immobilization, it should not be or be only 
minimally affected by the diminishing incubation time. The results presented in figures 32-34 
(four separate studies) confirm this trend. The IDA-Co chelation system has high affinity 
enough for His6-tagged Fab molecules to make the immobilization occur almost instantly after 
the contact with the antibody solution. The response in 10 min incubations was on average 0.82 
± 0.15 (mean and standard deviation from all of the studies) and in o/n incubations 0.86 ± 0.13, 
respectively. The responses in 10 min and o/n incubations did not differ either within (first 
study: t2 = -1.6, P = 0.243, second study: t2 = -0.3, P = 0.778, third study: t2 = 0.5, P = 0.674 
and fourth study: t3 = 0.2, P = 0.881) or between the studies (t5 = -0.6, P = 0.567). T-test syntax 
and an example of the result output are presented in appendix B.  
 
Figure 32. Decrease in incubation time had effect only on the immobilization efficiency in 
random immobilization. Boxplot: the edges of the box are upper and lower quartiles, whiskers 
are minimum and maximum values and the median is a line inside the box. (SU-8 pieces from 
different wafers). 
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Figure 33. Immobilization efficiency in the random immobilization differed significantly 
between the longest and shortest incubation times whereas there was no difference in the 
oriented immobilization. (SU-8 pieces from the same wafer). 
Figure 34. Repeated comparison tests between 10 min and o/n incubations in oriented 
immobilization were in line with the previous results. Instead in the random immobilization the 
10 min incubation time should have given substantially lower responses compared to the o/n 
incubation. (SU-8 pieces from the same wafer). 
 
68 
 
In the first and second random immobilization studies (figures 32 and 33, respectively), the 
immobilization efficiency decreased by almost 40 %, when 10 min and o/n incubations were 
compared. In the first study, 10 min incubation response was 1.33 ± 0.30 and o/n response 2.27 
± 0.03, respectively. Similarly in the second study, the response in 10 min incubation was 1.17 
± 0.21 and in o/n 1.84 ± 0.29, respectively. In both studies, the difference between 10 min and 
o/n incubations was significant (first study: t2 = -5.1, P = 0.036, second study: t4 = -3.2, P = 
0.038). However, in the last study set, where only 10 min and o/n incubations were compared to 
each other repeatedly (figure 34), no significant difference was observed. The response in the 
first repetition study for 10 min incubation was 0.72 ± 0.54 and for o/n 0.80 ± 0.13, 
respectively. Similarly in the second repeated study, the response in 10 min incubation was 0.97 
± 0.45 and in o/n 0.97 ± 0.27, respectively. Moreover, the variation in the responses in random 
immobilization both between and within the different studies was considerable. Variation was 
especially high within the 10 min incubations. Furthermore, the responses in 10 min incubations 
were surprisingly high in random immobilization.    
7.3.2 Amount of antigen 
The minimum usable concentration of antigen was determined by diluting the originally used 
antigen / TBS solution (c = 0.025 mg/ml). The first study set (figure 35) was made with 
dilutions 1:1, 1:10 and 1:100 and the second set (figure 36) with dilutions 1:1, 1:2, 1:5, 1:10 and 
1:20. As can be seen from the figure 35, the chosen dilutions in the first set were too dilute and 
only low responses were obtained. Also with the second set similar characteristics were seen. 
There was a notable change in the slope of the dilution series curve already with dilution 1:2. 
Therefore, regarding the preliminary testing phase, the antigen concentration should not be 
changed from 0.025 mg/ml.  
 
 
69 
 
 
Figure 35. First dilution series offered a too fast decrease in the immobilization efficiency. (SU-
8 pieces from the same wafer).  
 
 
Figure 36. Already dilution 1:2 caused a notable change in the slope of dilution curve. (SU-8 
pieces from the same wafer). 
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7.3.3 Serum vs buffer 
Serum is a biological liquid, which contains lots of different molecules, like electrolytes and 
proteins, which can interfere the random immobilization whereas the oriented immobilization as 
a high affinity reaction should not be disturbed by the serum molecules. As can be seen from 
figure 37, the results in both immobilizations were as expected. In oriented immobilization, the 
response in buffer incubation was 0.68 ± 0.09 and in serum 0.60 ± 0.25, respectively, and no 
statistically significant difference was observed (t2 = 0.5, P = 0.655). In contrast, in random 
immobilization, the response within the serum incubation was almost 50 % smaller compared to 
the buffer incubation response (buffer: 1.10 ± 0.18, serum: 0.59 ± 0.10) causing statistically 
significant difference (t3 = 4.4, P = 0.019).    
Figure 37. Choice of dissolving agent had significant effect on the random immobilization 
whereas the oriented immobilization was not affected. (SU-8 pieces from the same wafer).  
 
In order to confirm the result, the buffer and serum immobilization study was repeated by 
applying 10 min and o/n antibody incubation times (study conducted twice). Again, the oriented 
immobilization should not be affected whereas the random immobilization should give lower 
responses in serum immobilization and when using shorter incubation time. As can be seen 
from the figure 38, the previously obtained result from the oriented immobilization was able to 
be repeated. In the first study, the responses in oriented immobilization did not differ either in 
10 min (buffer: 0.93 ± 0.18 and serum 0.66 ± 0.28; t3 = 1.4, P = 0.243) or in o/n incubations 
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(buffer 0.88 ± 0.04 and serum 0.83 ± 0.02; t2 = 2.4, P = 0.109). A similar result was observed 
from the second study (10 min incubation in buffer: 0.78 ± 0.18 and in serum: 0.66 ± 0.28; t3 = 
0.6, P = 0.576; o/n incubation in buffer: 0.76 ± 0.12 and in serum: 0.83 ± 0.02; t2 = -1.0, P = 
0.421). These results suggest that the choice of dissolving agent do not have an effect on the 
oriented immobilization even though the incubation time is diminished from o/n to 10 min.  
On contrary, in random immobilization, the combined study of incubation time and the choice 
of buffer did not confirm the previously obtained result. According to figure 38 (right panel, 
test2), it seems, that the shorter incubation time and serum as a dissolving agent would be more 
efficient compared to the o/n incubation and buffer as a dissolving agent. The result is not 
logical and more studies are needed. In the first study (test1), the response in 10 min incubation 
in buffer was 0.72 ± 0.54 and in serum 0.48 ± 0.16. The response in o/n incubation in buffer was 
0.80 ± 0.13 and in serum: 0.73 ± 0.04. Similarly in the second study (test2), the response in 10 
min incubation in buffer was 0.97 ± 0.46 and in serum 1.03 ± 0.21. The response in o/n 
incubation in buffer was 0.97 ± 0.27 and in serum: 0.63 ± 0.16. In both studies, the difference 
between buffer and serum was not statistically significant (first study (test1): 10 min incubation 
t2 = 0.8, P = 0.518 and o/n incubation t2 = 0.9, P = 0.466; second study (test2): 10 min 
incubation t2 = -0.2, P = 0.851 and o/n incubation t3 = 1.8, P = 0.160).  
Figure 38. Decrease in incubation time or the choice of the dissolving agent did not have an 
effect on the oriented immobilization whereas the results obtained with the random 
immobilization were not logical as the serum and shorter incubation time seemed to give better 
responses. (Both between and within the studies:  SU-8 pieces from the same wafer).  
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7.3.4 The effect of pH 
The effect of immobilization pH was studied as the random immobilization was executed in a 
lower pH than oriented immobilization. The IDA-Co –treatment in oriented immobilization 
increased the surface pH to near 8.50 whereas the pH in random immobilization was the 
physiological pH (PBS as the immobilization buffer). The results shown in figure 39 indicate 
that the buffer pH had only a minimal effect on the immobilization responses in random 
immobilization (pH 7.24: 0.69 ± 0.12, pH 8.05: 0.72 ± 0.15 and pH 9.93: 0.71 ± 0.14).  The 
results in oriented and random immobilizations are therefore comparable at least by the 
immobilization pH.  
Figure 39. Buffer pH did not have an effect on the immobilization efficiency in random 
immobilization.  
 
7.3.5 Surface modification: nanostructuring and plasma oxidation  
The oxygen plasma treatment of the immobilization substrate by RIE is known to increase the 
immobilization efficiency due to higher surface roughness and activation of functional groups 
[22]. Similar tendency is presupposed to happen with SU-8 surface. Figure 40 presents the 
results.  
In the oriented immobilization, the response in 5 s RIE-treatment was 1.0 ± 0.06, in 60 s RIE 
0.84 ± 0.23 and in control sample 0.67 ± 0.35, respectively. The difference between 5 s RIE-
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treatment and control sample was not significant (t1 = 1.3, P = 0.413), however, this is mainly 
explained by the high variation between the separate samples in the control group (absorbance 
in separate samples were 0.92 and 0.42). In random immobilization, the response in 5 s RIE-
treatment was 1.48 ± 0.10, in 60 s RIE 1.4 ± 0.06 and in control sample 0.88 ± 0.07, 
respectively. The 5 s RIE-treated surface gave almost 45 % higher response compared to the 
surface where no modification was applied. This yielded a significant difference (t1 = 7.0, P = 
0.026). In both immobilizations, the longer RIE-treatment did not improve the immobilization 
efficiency, but instead decreased the responses. Thereby a shorter treatment time should be 
used. When considering these results, it needs to be remembered that the effective 
immobilization area was not similar between RIE-treated and control samples as the RIE-
treatment lowers the contact angle. Therefore the droplet spread to a larger surface area within 
the RIE-treated samples.  
 
Figure 40. Plasma oxidation treatment improved the immobilization efficiency in both the 
random and oriented immobilizations, even though the difference was significant only in the 
random immobilization. The shorter treatment time of 5 s influenced the results more. (RIE 
denotes reactive ion etching; SU-8 pieces from the same wafer). 
 
The result from the nanostructure modification study is shown in figure 41. As could be 
expected, the higher surface area offered more immobilization sites and therefore more efficient 
immobilization in both immobilizations. The response in oriented immobilization for 
nanostructured SU-8 surface was 0.97 ± 0.13 and for planar surface 0.39 ± 0.06, respectively. 
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Similarly in random immobilization the result for nanostructured SU-8 surface was 1.34 ± 0.04 
and for planar surface 0.73 ± 0.32, respectively. The immobilization with nanostructured SU-8 
was 59 % higher in oriented and 45 % in random immobilization compared to the planar SU-8. 
The difference was significant in both immobilizations (oriented immobilization: t2 = 7.2, P = 
0.007, random immobilization: t2 = 3.2, P = 0.082).  
 
Figure 41. Surface modification either through plasma oxidation or nanostructuring caused 
improvements in the immobilization efficiency, but only in nanostructuring, in both 
immobilizations and in plasma oxidation, in random immobilization the differences were 
significant compared to their controls. (SU-8 pieces from the same wafer).  
 
To obtain similar efficient immobilization area in both the nanostructured and the planar 
surfaces, an additional RIE-treatment was applied. The hydrophobicity of the SU-8 surface is 
higher within the nanostructured SU-8 surface compared to the planar SU-8. Therefore, the 
droplet spreads to a much smaller area within the nanostructured surface compared to the planar 
surface. Results from this study are presented in figure 41.  
In oriented immobilization, the response in nanostructured and RIE-treated incubation was 0.52 
± 0.26 and in simple RIE-treated 0.50 ± 0.10, which did not give a significant difference 
between results (t2 = 0.1, P = 0.910). In contrast, in random immobilization the response within 
the combined surface modification incubation was almost 64 % higher compared to the sample 
without nanostructures (nanostructured and RIE-treated: 2.34 ± 0.52, simple RIE-treated: 0.84 ± 
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0.26) causing statistically significant difference (t3 = 4.4, P = 0.022). Surprisingly, the 
difference between planar SU-8 and simple RIE-treated SU-8, was not observed in neither of 
the immobilizations (in oriented immobilization in planar: 0.39 ± 0.06 and in RIE-treated: 0.50 
± 0.10 and in random immobilization in planar: 0.73 ± 0.32 and RIE-treated: 0.84 ± 0.26). This 
is not in line with the above presented results for RIE-treatment. 
7.3.6 Storage stability of immobilized antibody 
The results from the one week storage stability study indicate that the efficiency of the antibody 
is preserved regardless of the storing conditions (wet or dry, figure 42). Storing in dry 
conditions reduced the responses only by 7 % in oriented and by 17 % in random 
immobilization compared to the wet conditions (in oriented immobilization, dry condition: 0.60 
± 0.13 and wet condition: 0.56 ± 0.17 and in random immobilization, dry condition: 0.67 ± 0.12 
and wet condition: 0.81 ± 0.09). The difference was not significant in either of the 
immobilizations (in oriented immobilization: t3 = 0.3, P = 0.799 and in random immobilization: 
t3 = -1.6, P = 0.181). Thus, the efficiency of immobilized antibody is maintained in dry 
conditions at least when storing is within the one week period. The results from the o/n storing 
study (dry and wet conditions) were excluded from this thesis due to technical difficulties in 
maintaining the dry conditions. The wet paper was forgotten to be taken away from the lid of 
the microtiter plate.  
 
Figure 42. Immobilized antibody maintained its efficiency both in wet and dry storing 
conditions when one week storing was applied. (SU-8 pieces from the same wafer).   
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7.3.7 Storage stability of SU-8  
In order to find out whether or not the SU-8 surface is able to maintain its storage stability after 
fabrication and thereby the immobilization efficiency, if no surface treatments are applied and 
the storing is made in a normal cleanroom conditions, two sets of storage stability studies were 
executed. The first set included 1 and 2 weeks, and the second set 3 and 4 weeks storing times 
in addition of a freshly fabricated control surface. The results from SU-8 stability studies are 
presented in figure 43.  
In oriented immobilization, the response in 1 week storing was 0.78 ± 0.02, in 2 weeks 0.58 ± 
0.18 and in control sample 0.67 ± 0.36, respectively. Similarly, the response in 3 weeks storing 
was 0.99 ± 0.27, in 4 weeks 0.78 ± 0.06 and in their control sample 0.75 ± 0.04, respectively. 
Neither of the storing times differed significantly from their control samples (in 1 and 2 week 
study, 1 week storing time: t1 = -0.4, P = 0.738 and 2 weeks storing time: t1 = 0.3, P = 0.783; in 
3 and 4 week study, 3 weeks storing time: t1 = -1.3 , P = 0.418  and 4 weeks storing time: t1 = -
0.7 , P =0.584).  
In random immobilization, the response in 1 week storing was 1.43 ± 0.23, in 2 weeks 1.39 ± 
0.48 and in control sample 0.88 ± 0.07, respectively. Similarly, the response in 3 weeks storing 
was 1.02 ± 0.26, in 4 weeks 1.44 ± 0.10 and in their control sample 1.28 ± 0.17, respectively. As 
was with oriented immobilization, also in random immobilization the different storing times did 
not give significant difference compared to their control samples (in 1 and 2 week study, 1 week 
storing time: t1 = -3.2, P = 0.164 and 2 weeks storing time: t1 = -1.5, P = 0.369; in 3 and 4 week 
study, 3 weeks storing time: t1 = 1.2, P = 0.375 and 4 weeks storing time: t1 = -1.2, P = 0.371).  
Even though no statistical significance was observed between the different storing times, the 
slight variation in the mean values of the results would suggest that the immobilization studies 
at this preliminary stage should only be done onto the freshly fabricated SU-8 surface in order 
to be sure the difference in results is caused by the parameter under observation and not by the 
SU-8 surface.    
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Figure 43. Storing of SU-8 surface did not cause a significant difference between the 
immobilization results at least during four weeks period. (Within the study: SU-8 pieces from 
the same wafer and between the studies: SU-8 pieces from different wafers).  
 
7.4 Comparison of random and oriented immobilizations 
A total of 13 comparison studies of random and oriented immobilization studies were included 
in this thesis. The immobilizations were compared if the SU-8 pieces were from the same wafer 
and all the reagents were made at the same time. In 84.6 % of comparison studies, random 
immobilization gave higher responses compared to the oriented immobilization. Interestingly, in 
53.8 % of those, the random immobilization was over 30 % better than the oriented 
immobilization. The result is quite unexpected as the random, covalent immobilization is 
affected by many more variables compared to the oriented immobilization. Results are 
presented in appendix C.  
However, during the oriented immobilization studies, IDA solution was not prepared for 
purpose but beforehand to speed up the testing. A comparison test of fresh and aged (72 days 
old) IDA solution showed that there is a clear impact on the immobilization efficiency as the old 
solution gave almost 40 % smaller responses compared to the fresh solution. The average 
response for the fresh IDA solution was 0.79 ± 0.18 and for the old IDA solution 0.48 ± 0.09, 
respectively. Due to this difference, a correction factor was calculated for all of the studies were 
old IDA solution was used. The correction coefficient was calculated according to equation (14) 
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  d =  1-MEANoldMEANnew72  = 0,0054  (14) 
 
where MEANold was the mean value for the old IDA solution and MEANnew for the new IDA 
solution. As the obsolescence process can be considered to be a linear process, the correction 
coefficient was multiplied by the number of days the IDA solution was older than the freshly 
made (therefore a maximum value for multiplying is 72). Despite the correction, only in one 
case the situation changed in favor of the oriented immobilization (results not shown).  
Secondly, the proper functioning of IDA-cobalt chelation system was tested. If the chelation 
does not take place, all the oriented immobilizations on SU-8 surface would be random 
immobilizations. To verify the proper functioning, a study with an additional blocking step was 
conducted. In oriented immobilization, the additional blocking step was made after the cobalt 
incubation and in random immobilization before the antibody incubation. In oriented 
immobilization, this excess blocking step should not have any effect on the responses whereas 
in random immobilization a notable decrease should take place, because there is no functional 
group for the antibody to couple with. Control samples were normal oriented and random 
immobilizations described in the chapter 6.5 and samples with excess BSA-blocking, but with 
wrong antigen (AP).  
As can be seen from figure 44, the excess blocking step does not have an effect on the response 
obtained in the oriented immobilization (normal oriented immobilization: 0.58 ± 0.05, 
immobilization with two BSA-blockings: 0.54 ± 0.05), which indicates that the IDA-cobalt 
chelation system is working correctly. On contrary, in random immobilization, there is a 55 % 
decrease in immobilization efficiency if the excess blocking step takes place (normal random 
immobilization: 1.59 ± 0.11, immobilization with two BSA-blockings: 0.72 ± 0.14). In both 
immobilizations, the negative controls are working correctly and have only background 
absorbance from the SU-8 surface (oriented immobilization: 0.08 ± 0.00, random 
immobilization: 0.09 ± 0.00). Therefore, neither of the two potential reasons presented here 
explains the superiority of the random immobilization. 
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Figure 44. Number of BSA blocking steps had effect only on random immobilization, which 
suggests both the blocking and IDA-Co chelation steps are working correctly within the 
immobilizations presented in this thesis.   
 
In addition to comparing the responses obtained from the different studies, the immobilization 
methods were also compared in terms of remaining antibody –antigen complex stability after 
o/n TBS-treatment. The few conducted studies are presented in appendix D. According to the 
results, it seems, the o/n TBS treatment has equally impaired the antibody-antigen stability in 
both immobilizations when a new substrate was placed. In random immobilization, only on 
average 39.7 % of the obtained absorbance was remained after o/n TBS treatment. In oriented 
immobilization, the same was 37.2 %, respectively. Addition of a new antigen followed by a 
new substrate did not improve the responses. The incubated antigen did not have free sites for 
binding. These results suggest that the interaction of the chosen antibody-antigen model system 
has not high affinity enough for the immobilization studies. This could also be explanation to 
some of the unexpected results obtained in the immobilization parameter studies. The appendix 
D also presents results from the two studies where only random immobilization was studied in 
terms of remaining antibody-antigen complex stability. The obtained results were in line with 
the comparison study results presented above.   
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7.5 MALDI-measurements 
The MALDI-measurement spectra for planar and nanostructured SU-8 are presented in 
appendix E (a selection of successful experiments). Despite the efforts antigen detection on 
planar surfaces was not possible. This is not explained by the failure in antibody immobilization 
as a control sample (detection with substrate) gave a response (detection by eye). One potential 
explanation for the failure is the inadequate immobilization density in the planar surfaces for 
MALDI. This fact is supported by the better results obtained with the nanostructured surfaces 
both in random and oriented immobilizations.  
A total of five MALDI-experiments were done, from which two times only planar surfaces were 
experimented. During those two times, no signal was observed. Nanostructured surfaces were 
studied three times (two times random and once the oriented immobilization surfaces), from 
which two studies gave responses (shown in appendix E). These preliminary studies showed 
that the choice of immobilization method did not have an influence on the result. The most 
interpretable results were obtained when the surface was treated both with nanostructures and 
oxygen plasma.    
As can be seen from the spectra (appendix E), the peaks with SU-8 base are a bit shifted to the 
right compared to the spectra of the pure samples. This shifting might be caused by the higher 
position of the SU-8 surface compared to the actual metallic MALDI-base (SU-8 piece is glued 
to the MALDI-base). Another notable fact is that the peaks of α-MPA Fab F5 and MPA-AP are 
very close to each other in the spectra. Some kind of inner calibration should be done before the 
measurement, to be sure which one of them (antibody or antigen) causes the peak in MALDI-
spectrum. One solution could be to use another antigen, like MPA- human serum albumin 
(HSA), which has a clear difference compared to the spectrum of α-MPA Fab F5. But its 
spectrum resembles closely the spectrum of the applied blocking agent BSA, which would again 
lead to the misinterpretation of the peaks. Therefore, at least at this point, the sensitivity of 
MALDI is not enough to verify the suitability of the SU-8 as a MALDI-base. Careful testing 
and potential change in the immobilization procedure (e.g. in terms of antibody, antigen, 
blocking agent etc.) have to be considered.  
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7.6 Immunochip 
7.6.1 Contact angle tests 
Capillary-driven flow is enabled if the contact angle between SU-8 surface and the solution is 
near 40° as stated in our own study [37]. The measured contact angle between freshly fabricated 
SU-8 surface and α-MPA Fab F5 in PBS solution was around 75° (dashed line in figure 48). 
Thus, no capillary-driven flow is possible to be obtained in channel structures (figure 26), if no 
modification is done to the setup. A known solution would have been to choose the oxygen 
plasma treatment, because it makes the SU-8 surface more hydrophilic [80]. However, the fast 
hydrophobic recovery, discussed in chapter 3.4.2, makes it not an optimal choice. Therefore, 
other methods to decrease the contact angle between SU-8 and the antibody solution were tried 
to find.   
Tween, a well-known surfactant, was mixed to PBS and the contact angle of this PBST solution 
in different dilutions measured with SU-8 surface. The change in contact angle is presented in 
figure 45. The contact angle between pure PBS and SU-8 is shown as a dashed line. The contact 
angle was measured four times in a 2 min period from the same droplet. As the results show, the 
contact angle decreased significantly with the original PBST solution and its first dilution. The 
decrease in contact angle with these solutions would offer sufficient conditions for the capillary-
driven flow. The same PBST solution in different dilutions were placed in 50 µl droplets on SU-
8 surface and photographed after 10 min incubation (figure 46).  
 
Figure 45. Change in contact angle during a 2 min period between different dilutions of PBST 
and SU-8 surface. The dashed line indicates the contact angle between PBS and SU-8.  
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Figure 46. Different dilutions of PBST solution on SU-8 surface after 10 min incubation.  
 
Next, the same dilutions of PBST were fabricated, but this time also antibody was included to 
the solution and the contact angle measured with SU-8 surface. On basis of the first contact 
angle study (figure 45), the fourth and fifth dilutions of PBST were excluded due to incapability 
to lower the contact angle. The change in contact angle is presented in figure 47. The contact 
angle between SU-8 and α-MPA Fab F5 in PBS solution is shown as a violet dashed line. The 
study showed that the only solution capable to produce the correct angle was the original PBST 
solution (0.05% PBST + F5). Even though the adjustment of the contact angle was correct with 
the original PBST solution, the use of it was prevented due to significant drop in the 
immobilization responses as shown in figure 48. The responses with both the original PBST-
solution and its first dilution were 51 % and 45 % lower, respectively, compared to the control 
sample, which included antibody in normal PBS (PBST: 0.54 ± 0.05, 1. dilution of PBST: 0.61 
± 0.16 and control: 1.11 ± 0.13). Therefore, oxygen plasma treatment was chosen to be the 
method to lower the contact angle on SU-8 surface. 
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Figure 47. Change in contact angle during a 2 min period between different dilutions of 
antibody - PBST solution and SU-8 surface. The dashed line indicates the contact angle between 
antibody - PBST solution and SU-8.  
 
 
Figure 48. Tween should not be used in the antibody immobilization as the immobilization 
efficiency of antibody is decreased significantly in random immobilization when higher 
concentrations of Tween are used.  
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7.6.2 Liquid flow studies 
The correct layer depth and distance between consecutive rows (see table 7) for the immunochip 
design was decided by the liquid flow studies. The test was executed with water and antibody 
solution. The tested contact angles were 30º and 42 º.  
The flow studies were not successful with contact angle of 30° with any of layer thicknesses. 
The wrong contact angle allowed the liquid to flow in both directions (upwards and downwards 
after the inlet whereas the desired path was only upwards). The studies indicated that the correct 
flow profile was obtained when the contact angle was around 42°. This result was repeated both 
with the water and the antibody solution. In addition to contact angle, also the layer thickness 
and the consecutive row distance of the structures were defined. The correct flow profile was 
obtained with 14.8 µm thick SU-8 layer, where the row distance was 23 µm (figure 49). Also 
this was able to be repeated with both the water and the antibody solution. Appendix F presents 
the incorrect flow profiles in the most common problem situations and a more detailed photo 
series of the correct flow profile (made with water).  
During the flow studies, we noticed that in addition to proper contact angle and the SU-8 
structure parameters, the flow profile is as dependent on the humidity of the surroundings. If the 
surroundings are not humid enough, the liquid flows correctly at first, but due to evaporation of 
the PBS (in antibody solution), after a 20 s period, the flow is also directed downwards (see 
appendix F). The studies showed that the droplet dries in about 1 min. Therefore, some kind of a 
box with a cover is needed when using the immunochips.  
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Figure 49. The correct flow profile with antibody solution was obtained when the chip was 
sealed inside a covered Petri dish (contact angle: 42°). The progress of the  solution is marked 
with red arrow.  
7.6.3 Immobilization tests using immunochip structures 
We did over 30 different immobilization studies with immunochip structures according to 
random immobilization shown in table 9. On the basis of the previous studies made within this 
thesis, the correct contact angle and structure parameters (see chapter 7.6.2) as well as the 
requirement for humid conditions were implemented to the studies. The correct flow profile was 
obtained couple of times and one of the most promising samples was taken to the fluorescence 
detection. The results (figure not shown) indicated that some kind of immobilization had taken 
place. The fluorescence was the most efficient on the tips of the triangles as the illustrative 
figure 50 presents. In order to be sure, that the fluorescence was caused by the correct 
immobilization and not e.g. by the evaporation of the buffer, more repetitions are needed.  
 
 Figure 50. An illustrative presentation of the fluorescence microscope detection obtained from 
the immunochip study. The red circles present the places where the fluorescence was highest.  
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8 Conclusion 
This thesis studied the His6-tagged α-MPA Fab F5 immobilization onto SU-8 surface by 
random covalent and IDA-Co chelation immobilizations. The scope was to compare these two 
immobilization methods in terms of various immobilization parameters. In addition, the aim 
was to observe wheatear or not SU-8 is a feasible base material for MALDI-MS. Also the 
determination of the optimal conditions as well as the fabrication parameters for the 
immunochip structure was the scope of this thesis.  
The results obtained in this thesis indicate that the antibody immobilization is possible with both 
immobilization methods. Moreover, in both immobilizations neither the SU-8 surface storing 
stability nor the dry storing conditions distract the immobilization significantly, which are 
desired results by thinking the potential applications. The results in oriented and random 
immobilization were promising, but still more repetitions are needed. In comparison studies the 
random immobilization was better in antibody immobilization efficiency. But even though the 
responses in random immobilization were notably higher throughout the studies, the higher 
variation between parallel samples and therefore poorer repeatability would suggest that the 
oriented immobilization is more desired in the applications.  
In addition to antibody immobilization, we were able to show that SU-8 is potentially applicable 
to be used as a MALDI-base, if further considerations regarding the surface modification by 
oxygen plasma and nanostructuring are taken into account. We also presented the fabrication 
parameters and surface modification prospects to the correct operation of the innovative 
immunochip structure. 
In the future, the immobilization should be done with smaller SU-8 pieces, which would enable 
the immersion based immobilization or in a microtiter plate, which would have been fabricated 
entirely of SU-8. In addition, a new antibody-antigen model system, which would have higher 
affinity, should be used. The change in antibody-antigen pair would also be beneficial regarding 
the MALDI-measurements as in the current immobilization the BSA blocking solution, 
antibody as well as the antigen are very close to each other in the spectra. It is difficult to 
determine which of them caused the change in the spectrum.  
At least to our knowledge there are no previous studies showing the recombinant antibody 
fragment immobilization onto SU-8 surface. Overall the number of studies regarding the 
antibody immobilization onto SU-8 is scarce despite the fact SU-8 is known to be sufficiently 
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biocompatible and that there are also plenty of different surface modification methods 
developed, which are able to activate the existent residual epoxy groups and to pose new 
functional groups on SU-8. Therefore, this thesis contributes to the current understanding of 
how the antibody immobilization is done onto SU-8 surface. In addition, this thesis serves as a 
guideline to follow-up studies and further development steps as well as a comprehensive review 
on SU-8 both in properties, fabrication methods and surface modification prospects. 
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Appendix A. ATIR-FTIR results of different SU-8 samples 
 
Table 1. The relevant peaks in the SU-8 ATIR-FTIR spectrum.  
 
WAVENUMBER (cm-1) CHARACTERISTIC VIBRATION 
861 C–O stretching of cis substituted epoxy 
rings 
910 C–O stretching of trans substituted epoxy 
ring 
1000–1230 C–O–C stretching in ethers 
1000–1290 C–O stretching in phenols and secondary 
alcohols 
1500 Aromatic C–C stretching (in-ring) 
1700–1750 C=O stretching cyclopentanone (solvent) 
 
 
 
Figure 1. ATIR-FTIR spectrum of sample2.  
 
2 
 
 
Figure 2. ATIR-FTIR spectrum of sample3. 
 
 
 
 
Figure 3. ATIR-FTIR spectrum of sample4. 
 
3 
 
 
Figure 4. ATIR-FTIR spectrum of sample5. 
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Appendix B.Statistical testing by Student t-test: R syntax and output 
9.1.1 R syntax for Student’s t.test  
t.test(x, ...) 
 
## Default S3 method: 
t.test(x, y = NULL, 
       alternative = c("two.sided", "less", "greater"), 
       mu = 0, paired = FALSE, var.equal = FALSE, 
       conf.level = 0.95, ...) 
 
 
Parameter definition: 
a <- c(0.95, 0.94, 0.58) 
b <- c(1.08, 0.96, 1.02) 
 t.test(a, b) 
 
Result output: 
 Welch Two Sample t-test 
 
data:  a and b 
t = -1.5542, df = 2.322, p-value = 0.2433 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.6747898  0.2814565 
sample estimates: 
mean of x mean of y  
0.8233333 1.0200000 
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Appendix C. Comparison study results: random and oriented immobilization 
 
Table 1. Comparison tests results (same SU-8 wafer and reagents fabricated same time).  
 
STUDY SAMPLE IMMOBILIZATION TYPE 
ABSORBANCE 
(mean ± sd) 
BETTER  IN 
RESPONSE 
Incubation time 
10 min 
random 1.17 ± 0.21 
random 
oriented 0.83 ± 0.21 
2 h 
random 1.19 ± 0.32 
random 
oriented 0.80 ± 0.09 
o/n 
random 1.84 ± 0.29 
random 
oriented 1.02 ± 0.06 
Incubation time 
10 min 
random 0.72 ± 0.54 
oriented 
oriented 0.93 ± 0.18 
o/n 
random 0.80 ± 0.13 
oriented 
oriented 0.88 ± 0.04 
Incubation time 
10 min 
random 0.97 ± 0.45 
random 
oriented 0.77 ± 0.18 
o/n 
random 0.97 ± 0.27 
random 
oriented 0.75 ± 0.12 
Amount of antigen 
1:1 
random 0.59 ± 0.20 
random 
oriented 0.39 ± 0.10 
1:10 
random 0.23 ± 0.05 
random 
oriented 0.15 ± 0.03 
1:100 
random 0.08 ± 0.01 
- 
oriented 0.08 ± 0.00 
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STUDY SAMPLE IMMOBILIZATION TYPE 
ABSORBANCE 
(mean ± sd) 
BETTER  IN 
RESPONSE 
Amount of antigen 
1:1 
random 0.72 ± 0.21 
random 
oriented 0.44 ± 0.09 
1:2 
random 0.50 ± 0.13 
random 
oriented 0.39 ± 0.13 
1:5 
random 0.29 ± 0.05 
random 
oriented 0.19 ± 0.06 
1:10 
random 0.22 ± 0.02 
random 
oriented 0.15 ± 0.01 
1:20 
random 0.13 ± 0.01 
random 
oriented 0.12 ± 0.01 
Serum vs. buffer 
incubation 
Buffer 
random 1.10 ± 0.18 
random 
oriented 0.68 ± 0.09 
Serum 
random 0.59 ± 0.10 
oriented 
oriented 0.61 ± 0.25 
Serum vs. buffer 
incubation & 
incubation time 
Buffer 10 
min 
random 0.72 ± 0.54 
oriented 
oriented 0.93 ± 0.18 
Buffer o/n 
random 0.80 ± 0.13 
oriented 
oriented 0.88 ± 0.04 
Serum 10 
min 
random 0.48 ± 0.16 
oriented 
oriented 0.66 ± 0.29 
Serum o/n 
random 0.73 ± 0.04 
oriented 
oriented 0.83 ± 0.02 
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STUDY SAMPLE IMMOBILIZATION TYPE 
ABSORBANCE 
(mean ± sd) 
BETTER  IN 
RESPONSE 
Serum vs. buffer 
incubation & 
incubation time 
Buffer 10 
min 
random 0.97 ± 0.45 
random 
oriented 0.77 ± 0.18 
Buffer o/n 
random 0.97 ± 0.27 
random 
oriented 0.75 ± 0.12 
Serum 10 
min 
random 1.03 ± 0.22 
random 
oriented 0.69 ± 0.03 
Serum o/n 
random 0.63 ± 0.17 
random 
oriented 0.59 ± 0.12 
Surface 
modification by 
nanostructuring 
and RIE 
Nano 
random 1.35 ± 0.04 
random 
oriented 0.97 ± 0.13 
Planar 
random 0.73 ± 0.32 
random 
oriented 0.39 ± 0.05 
RIE 
random 0.83 ± 0.26 
random 
oriented 0.50 ± 0.09 
Nano + RIE 
random 2.34 ± 0.53 
random 
oriented 0.52 ± 0.26 
Surface 
modification by 
RIE 
Control 
random 0.88 ± 0.07 
random 
oriented 0.36 ± 0.36 
5 s RIE 
random 1.48 ± 0.10 
random 
oriented 1.00 ± 0.06 
60 s RIE 
random 1.39 ± 0.06 
random 
oriented 0.83 ± 0.23 
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STUDY SAMPLE IMMOBILIZATION TYPE 
ABSORBANCE 
(mean ± sd) 
BETTER IN 
RESPONSE 
Immobilized 
antibody stability 
Wet 
random 0.81 ± 0.09 
random 
oriented 0.56 ± 0.17 
Dry 
random 0.67 ± 0.12 
random 
oriented 0.60 ± 0.13 
Storage stability of 
SU-8 surface 
1 weeks 
random 1.43 ± 0.23 
random 
oriented 0.78 ± 0.02 
2 week 
random 1.39 ± 0.48 
random 
oriented 0.58 ± 0.18 
Control 
random 0.88 ± 0.07 
random 
oriented 0.67 ± 0.36 
Storage stability of 
SU-8 surface 
3 weeks 
random 1.02 ± 0.26 
random 
oriented 0.99 ± 0.27 
4 weeks 
random 1.44 ± 0.10 
random 
oriented 0.78 ± 0.06 
Control 
random 1.28 ± 0.17 
random 
oriented 0.75 ± 0.04 
9 
 
Appendix D. Comparison study results: Antibody-antigen complex stability in o/n TBS 
treatment 
 
Table 1. Remaining activity of the antibody-antigen complex after o/n TBS treatment. 
STUDY SAMPLE IMMOBILIZATION TYPE 
REMAINING IMMOBILIZATION 
EFFICIENCY (%: mean ± sd) 
NEW SUBSTRATE NEW ANTIGEN & SUBSTRATE 
Antibody 
incubation 
time 
10 min 
random 16.4 ± 1.5 
Not measured 
oriented 37.6 ± 10.5 
2 h 
random 21.4 ± 6.0 
oriented 31.7 ± 3.2 
o/n 
random 20.2 ± 3.5 
oriented 29.4 ± 11.7 
Amount of 
antigen 
1:1 
random 40.8 ± 5.0 27.0 ± 5.0 
oriented 32.1 ± 4.4 27.8 ± 5.3 
1:2 
random 40.3 ± 7.4 30.6 ± 9.9 
oriented 29.8 ± 7.7 30.8 ± 7.0 
1:5 
random 42.6 ± 4.0 37.0 ± 5.9 
oriented 51.5 ± 14.9 49.8 ± 14.1 
1:10 
random 50.1 ± 6.8 49.8 ±7.6 
oriented 56.0 ± 3.5 59.6 ± 2.3 
1:20 
random 67.1 ± 5.9 64.9 ± 7.4 
oriented 71.7 ± 10.6 69.6 ± 7.6 
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STUDY SAMPLE IMMOBILIZATION TYPE 
REMAINING IMMOBILIZATION 
EFFICIENCY (%: mean ± sd) 
NEW 
SUBSTRATE 
NEW ANTIGEN 
& SUBSTRATE 
Serum vs. 
buffer 
Buffer 10 
min 
random 33.9 ± 4.0 
Not measured 
oriented 25.8 ± 3.0 
Buffer o/n 
random 45.2 ± 4.4 
oriented 28.2 ± 2.6 
Serum 10 
min 
random 52.9 ± 35.6 
oriented 34.5 ± 6.2 
Serum o/n 
random 68.8 ± 21.7 
oriented 43.4 ± 7.8 
Serum vs. 
buffer 
Buffer 10 
min 
random 34.2 ± 11.8 
Not measured 
oriented 22.9 ± 2.2 
Buffer o/n 
random 28.6 ± 4.2 
oriented 27.0 ± 2.4 
Serum 10 
min 
random 39.3 ± 7.7 
oriented 40.4 ± 18.7 
Serum o/n 
random 33.5 ±7.1 
oriented 32.7 ± 3.4 
Buffer pH 
pH 7.24 
random 
42.2 ± 5.1 29.2 ± 5.7 
pH 8.05 37.7 ± 7.9 30.7 ± 4.4 
pH 9.93 47.5 ± 9.4 34.7 ± 9.5 
Surface 
modification 
Nano 
random 
15.7 ± 2.0 14.1 ± 1.3 
Planar 20.4 ± 8.5 17.1 ± 9.8 
RIE 21.9 ± 6.0 17.5 ± 4.0 
Nano + RIE 17.2 ± 8.6 12.7 ± 6.5 
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Appendix E. MALDI spectra.   
 
Figure 1. MALDI spectra of SU-8 surfaces with random immobilization and reference spectrum 
for antibody and antigen. 
 
 
Figure 2. MALDI spectra of SU-8 surfaces with oriented immobilization and reference 
spectrum for antibody and antigen 
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Figure 3. BSA reference spectrum on SU-8 (500 shots). 
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Appendix F. Liquid flow studies 
- Incorrect behavior, because of wrong contact angle: the liquid flows up- and 
downwards from the inlet. 
 
Figure 1. Due to too low contact angle, the liquid flows up- and downwards from the 
inlet. SU-8 layer is 17.8 µm thick and the contact angle is 26.5°. 
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- Incorrect behavior, because of the PBS evaporation: the liquid flows correctly at first, 
but after a while the liquid flows also downwards.   
    
  
Figure 2. The liquid flow in 14.8 µm thick SU-8 chip when contact angle is 42° and the 
surrounding humidity is not controlled (time period 1 min and consecutive row distance 
in channel 23 µm). 
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- Correct behavior (made with water): 
    
   
Figure 3. The water flows only upwards from the inlet when contact angle was 42°, SU-
8 layer thickness 14.8 µm and the humidity under control (the red arrow indicates the 
current position of the proceeding liquid). Adapted from ref. [112]. 
